Podcasts about Ors

CADENA 100 presenta su Noche de CADENA 100 con artistas como Melendi, David Bisbal, Loreen y Maldita Nerea. En 'Mateo & Andrea', comentan sobre un gimnasio de Tenerife que usa pulseras de colores para el estado civil y juegan a adivinar canciones. Un oyente, Daniel, supera a Sazán identificando temas de Jarabe de Palo, David Tavares y Anastasia. Además, se informa que Robbie Williams pospone su álbum 'Brit Pop' para evitar competir con Taylor Swift y perseguir su récord de números uno. Jesús Ors pincha música de Dani Fernández y DJ Snake con Justin Bieber, y cuenta el origen de un famoso tema de Guru Josh con su icónico saxofón. Una oyente, Valeria, de Zaragoza, agradece a la emisora por su compañía.

Una nave de madera en el espacio demuestra su resistencia y capacidad de desintegración al regresar, lo que ofrece una solución para la basura espacial. CADENA 100 presenta a las guerreras K-Pop con Golden, quienes agotan entradas en A Coruña y Vigo, y a Taburete. Fito suena en la radio mientras se anuncia la 'Noche de CADENA 100', a beneficio de Manos Unidas, con David Bisbal, Beret y Melendi en el Movistar Arena. Dani Martín celebra 25 años de carrera con su nueva canción "25", un recorrido nostálgico por éxitos como "Zapatillas" y "16 añitos". En 'Mateo & Andrea', Eva gana un altavoz de CADENA 100 al identificar a Ricky Martin, Eros Ramazzotti y Adele. Jesús Ors ofrece 45 minutos de música sin interrupción, con temas de Bruno Mars, Abraham Mateo y Damiano David junto a Tyla. La previsión del tiempo indica sol y buenas temperaturas para mañana. CADENA 100 se consolida como la mejor variedad musical.

CADENA 100 presenta a Gonzalo Hermida, un compositor muy emocional que lanza un nuevo álbum. El programa 'Mateo & Andrea' juega con Lucía, una oyente que, de vuelta a Talavera de la Reina, gana un altavoz al identificar canciones, como "Las de la intuición" de Shakira, más rápido que el Shazam del programa. En otro momento, se comenta la situación de una pareja por unas medicinas naturales que huelen mal. Manuel Carrasco reflexiona sobre sus duros inicios tras 'Operación Triunfo', cuando pasó de grandes audiencias a solo 300 personas, y cómo esa experiencia fue fundamental para forjar su exitosa carrera actual. Jesús Ors pone 45 minutos de música sin interrupción con artistas como Alex Warren e Icona Pop, y menciona 'El Canto del Loco' y Amaia. Se invita a los oyentes a compartir sus historias para empezar la semana.

Dr. Stuart Grant, founder of Archetype Medtech, shares his journey designing and delivering breakthrough orthopedic and surgical innovations across the UK, US, and China. Stuart recounts how an early internship led him into medtech, what kept him there, and how building the ASPAC Innovation Center in China helped accelerate a total knee instrument system that dramatically reduced time to market. He explains the leap from corporate leader to entrepreneur: planning for years, earning a PhD in Medtech Product Innovation, and building a consultancy that helps startups and scale-ups turn early clinical unmet needs into market-ready, regulator-approved devices through a network of experts and an “expertise for equity” model.    Guest links: https://archetype-medtech.com/  Charity supported: Sleep in Heavenly Peace Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 074 - Stuart Grant [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of the Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome Dr. Stuart Grant. Dr. Grant is a chartered engineer and the founder of Archetype Medtech, a consultancy and innovation studio helping medical device startups and scale ups transform early clinical, unmet needs into market ready products. With nearly 25 years of experience, Stuart has led global teams across the UK, US, China, and emerging markets delivering breakthrough innovations in hip, knee, shoulder, and trauma surgery. A highlight of his career was establishing the ASPAC Innovation Center in China, where he built R&D capability from the ground up and launched a pioneering total knee instrument system that dramatically reduced time to market. Passionate about advancing medical technology and mentoring future engineers, he bridges creativity, engineering, and regulation to accelerate safer, smarter medtech innovation worldwide. All right. Welcome to the show. It's so great to have you here today. Thanks for joining me. [00:01:57] Stuart Grant: It's lovely to be here, Lindsey. [00:01:58] Lindsey Dinneen: Yeah. Excellent. Well, I was wondering if you could start by sharing a little bit about yourself, your background, and what led you to medtech. [00:02:08] Stuart Grant: Yeah. So, I was actually, I'm obviously, as you can tell from my accent, I'm British, but I was born in Germany because my, my dad was in the military in the 1970s when I was born. So I was born actually in Berlin, which is quite interesting to be a place to be, grew up in. So I traveled around a lot here in the UK, in Germany with my dad getting posted everywhere. My mom's a nurse. So I was in medtech, not really knowing I was in medtech as a kid, but I, my family was, so yeah. And then obviously went to school, all the places I was at university. I went to university to do product design, and my goal was to be a product designer, a cool product designer, designing fancy products like Johnny Ive. And when I was looking for a job as a co-op, or an intern as you call them in the US, I was just really unsuccessful finding a job. I was doing a lot of interviews, getting turned down, sending my CV out a lot, and j happened just to advertise on the Board of University, and it said Johnson Orthopedics and no one really knew what that was in. And none of my fellow students at applied because they thought it would be designing baby bottles for putting talcum powder in and shampoo in and stuff like that. So they're like, "I'm not doing that job." So I desperately applied for it and luckily found out about all this medtech, and I've been here doing medtech for 25 years. So they gave me a job. I had to work hard to keep the job and get reemployed over and over again. But yeah, joining originally Johnson Orthopedics a long time ago is how I found out about medtech. I never knew when I was 18 that really it was a thing that existed. [00:03:47] Lindsey Dinneen: Yeah. So, okay. So you thought product design, and then when you got into medtech, what were some of the things that attracted you and that actually compelled you to stay and make a career out of it? [00:04:00] Stuart Grant: Ha. So I was a young guy with the student debts. What compelled me, I was getting paid to stay, but not to be too flippant about it, but, you know, when I was doing this engineering and design work in my early days in the CAD system, it was just so interesting. I was designing these products that were going into people or the instrumentation to make help the surgeon and going to these ORs and watching the surgeon do their job and trying to figure out how how I can make it better from their input was really interesting. I could apply it straight away, basically. In the early two thousands, there wasn't all these regulations and standards that slowed you down. So you could go and design an instrument, get it machined in the machine shop, get it clean, take it to the surgeon, he can use it, you know, probably be frowned upon 25 years later. But that's what we used to do and really adapt. And probably more interesting than going into product design and fast moving consumer goods where you're designing a, a kettle or a toaster or something, a plastic casing. It was actually much more interesting to do that. And I stayed because I spent four years here in Leeds, in the UK, was getting a bit bored and wanted to find something else to do, and then an opportunity came up in the US. So I moved over to Warsaw, Indiana, the orthopedics capital of the world, as you might know it. Worked there for, stayed there for seven years. Really enjoyed it.. People sort of bemoan Warsaw for being in the sticks in just a bunch of cornfields around it. But I enjoyed it. It's got, we had a good bunch of young friends there. I was in late twenties, early thirties at the time. There was Noah and Spikes. You'd go for a drink and some nice food. It was all right. I enjoyed my time and after that I was, after seven years, I was like, "Okay, what do I do next?" And I was looking around for jobs in medtech. Then another opportunity came up in and we were looking for people to go over and help set it up, train the staff on what MedTech product development was. And so I jumped to the chance and spent five years living in China, in Shanghai. After five years is your limit, so I had to come home. I couldn't stay. I wanted to stay, but they wouldn't allow me to. So, so I came back to the UK. And then started MDR for five years as leading the Joints MDR program, which was lots of fun, as you could probably tell, wasn't really R&D, was a lot of leadership and project management and dealing with a lot of people and a lot of problems on a day-to-day basis. And so, yeah, after that I I left J&J about three years ago and started my own product development agency. And we can talk about a little bit about that later. So that's where I am and where I got to. [00:06:50] Lindsey Dinneen: Excellent. Yeah, I definitely wanna talk about that as well. But going back a little bit-- and perhaps this is actually something that's occurred since you started your own company as well-- but are there any moments that really stand out to you along your journey of affirming that, "Hey, yeah, I actually am in the right place, in the right industry?" [00:07:12] Stuart Grant: That's a really hard one is sort of the, is the grass always greener somewhere else, type of question. Right? I guess compare, you shouldn't compare, but comparing to my friends at my university, my product design and what they've done and what I've done they've moved into the car industry a lot. Went to the car development and car industries always had its ups and downs and its problems. And you know, they've had some really cracking jobs working for McLaren and Ferrari and you know, but I think just the interesting things that medtech do that nobody really knows about is really what keeps me moving along and having conversations with people when they, you tell them like, "I used to design hips and knees and shoulders and things like that," and they're like, "Oh, my mother's got a hip and knee" and blah, blah, and you really talk about it. Actually, my mother does have a hip now and she's going in a couple months time to get the other hip done. I do know what brand she's got, so. [00:08:10] Lindsey Dinneen: See, that's really cool. Yeah. Okay. So, so, on your LinkedIn I noticed that you describe yourself as a fixer, a challenger, and a change maker, which I love. But I'd love to hear from you exactly what you mean by all those things as you have developed in your career, and now as you're doing, of course, your own consulting. [00:08:34] Stuart Grant: Yeah, so in Johnson and my colleagues are probably, I agree with this, I had a bit of a reputation of getting the more difficult projects. The, that's probably why I got MDR in the end 'cause I would always get the projects that had problems and I enjoyed that. I liked digging deep and solving the problem and wrangling everyone together and pushing everybody along to help. And that was actually one of the reasons why I moved to the US 'cause the original project I moved to was the project leader left and it was in a bit of a shambles. So I went over to sort of, sort of try and get it together and just ended up staying and working on multiple projects. So I like that. Really challenging, not just the engineering side. The engineering side is obviously really interesting, but the challenging project management and people management and process management in a big corporation, all of those things, people, product, process, all come together just to cause a big headache sometimes, you know, herding cats as say and going, trying to solve those problems as an engineer, always trying to solve these problems, right? So it's you're always trying to figure out how you can move forward. [00:09:52] Lindsey Dinneen: Yeah. Yeah, absolutely. So, okay, so that kind of brings us to the company. So what was it like going from employee to entrepreneur? Were you, did you feel ready and prepared for that leap? Or what has that transition and pathway been for you? [00:10:10] Stuart Grant: So I've, I was a long-term planner. I was planning for this for five years whilst I was working for Johnson. So I went and got, when I came back to the UK I started my PhD and I knew getting a PhD was a real way of building credibility immediately, right? Before you step in a room and have a conversation with you, if you've got a PhD in the subject you're about to talk about, people pay attention, hopefully. Right? So I did my, so I did my PhD in Medtech Product Innovation, what the process is. So I spent seven years part-time working for Johnson, getting my PhD, knowing that eventually in my mid forties, there'll be an inflection point, which usually isn't people in big corporations, right, that either stay to the end for until you're six, mid sixties. If you hit 50, usually stay for the next decade, right? Or you leave and do something else. And I was like, "Okay, 45, I'm gonna pull the bandaid, go in, get my PhD, set up my own company plan, get the plan to do it, get the savings," and so I was working on MDR and a new MDR was coming to an end, and then they'd have to find me a new project, which probably didn't exist. So I also knew that J&J would be like, "Ah, Stuart, you've been here for 23 years. There's not really anything of your level here." I'd be like, "Great, let's go." So this was all a, you always it's a big step, right? I have a family. I can't just sort of walk in, not come in the office anymore. So it was a big plan that my wife and I had for quite a number of years to execute. So it's still a struggle. I've been doing it for three years. It's still hard work, still building the company, finding clients, understanding what their pain points are and improving your picture and all those other things, still is still a challenge, but it's a new challenge. [00:12:06] Lindsey Dinneen: Yeah. [00:12:07] Stuart Grant: And as I say, as I said, when people worry about the risk, it's like I can easily just go and get a corporate job again as a move back and have all this new relevant experience. So it's a risk, but you have to balance that by the benefits. [00:12:21] Lindsey Dinneen: Yeah, calculated risk that you've planned for, so good for you. So, okay, so tell us a little bit about your company now and who you help and kind of where in the development or even ideation process that you can come in and really make a difference. [00:12:40] Stuart Grant: So, yeah, so Archetype MedTech is a product development, product innovation agency. And what we do, we usually work with startups or scale ups. Startup side, they'll have a proof of concept. They've already defined the unmet clinical need. They've sort of wrangled the technology and validated the actual technology does what it they're trying to make it do, but they just dunno how to make this a medical device product, right? They've they've got the technology, but they dunno how the product make a product that's sellable is releasable and it gets approved by FDA or here in the, i'll say here in the EU, I know I said in the UK, but MDR and I help them work out that product innovation strategy. So take them all through either they need to do the frontend innovation and understand their needs and the insights and the business case, and then the engineering requirements and specifications. The design and engineering part I help them with, and this is not just me. I have a network of experts, a sort of consortium of experts that come together and bring all these different specialties and then we help them with the testing, what testing they need to do, their risk management, usability, all that fun stuff. And then contact and help them work with the manufacturers. So contract manufacturers, then their regulatory approval. So really what we try to do is, 'cause we're bringing all this expertise as a group of people together, the entrepreneur, usually a salesman or surgeon at this point, who may be a university spin out, can spend a lot of time and money trying to find these experts, trying to find these resources, trying to understand the product development, the MedTech product development process, which is all written down in various books, but when you get down to the details, it gets really complicated. So what we do is help them go through that as fast and as efficiently as a possible, so they're not wasting capital fishing around for those experts. We already have that network of experts that we can bring in and take them through the process as quickly as possible. So that's what Archetype Medtech do for our clients. And has been successful. We have quite a number of clients, mostly in orthopedics and surgical 'cause that's my specialty in medtech. And what we also do, we just don't want to be a management consultancy firm. Well, we do if it's right, we share what we call expertise for equity. So we'll take some equity from the company, but we'll cut our day rates or maybe do it for free, do and help them go through the process as quickly as possible. That means we've got skin in the game, right? We're not just taking their money and going, "Great. This is great. Good luck on the commercialization. Not our problem." [00:15:29] Lindsey Dinneen: Right. [00:15:30] Stuart Grant: It is our problem. 'cause we want a return on our risk and our investment as well. So, yeah, that's what we try to do. And along with that we do a load of pro bono work with surgeons in the NHS who have had ideas. We help them just get their idea a bit further along so they can start looking for funding and investment, and I can share that with you later 'cause it's a really important program that the NHS run it. If there's any mentors out there that want to get involved I can point them in the right direction. [00:16:00] Lindsey Dinneen: Actually that's fantastic and I would love to hear a little bit more about the organization and yeah, how people can get involved and help and what do they all do. [00:16:10] Stuart Grant: Yeah. So the NHS have set up this called NHS Clinical Entrepreneurs Program. This is not my company. This is a completely separate organization. And what it is, clinicians, anybody who works in the NHS-- you know NHS is a 1.6 million people who are employed in the NHS. It's a massive company organization. They come up with clinical needs 'cause they're in the problem and they start working out how they solve it, even through medical device or health tech or an app or anything, right? And they can go into this, it is basically the equivalent of an accelerator program over about nine months. And we have mentors like myself who work with those clinicians to help them develop their idea. So I've got a couple of clinicians that I work with. One is developing a neurosurgical device for helping him cut out tumors in the brain. At the moment, they use two tools. They use a scalpel and a cordy, a bipolar cordy, and they're very basic tools. And what he has to do, he's under a microscope, and he has to swap these one by one, does this scalpel to cut the vascularization of the tumor. Then he has to seal it. And he has to pass the nurse has to pass in these tools and he can't see a, see the nurse passing him. So he is like, "Can I develop a tool that's in one a scalpel and a bipolar" so he doesn't have to keep changing the tool in his hand? And you can know by the cognitive load and changing that tool in the field that these surgeries take eight to 12 hours to cut out a tumor from the brain. So he's saying every, he swaps his tool about 200 times and it takes three seconds. So you can start doing the maths. [00:17:59] Lindsey Dinneen: Yeah. [00:18:01] Stuart Grant: Yeah. And then the other, so the other is a doctor, actually, the doc is a neonatal doctor and he's trying to develop a langoscope for neonatal babies. The langoscopes at the moment haven't really improved in the last 60 years. The Muller blades, they're called, and they're the stainless steel things that basically adult ones have been shrunk down to baby size and changed a little bit. They're not very good. And when you've got a newborn baby who's struggling to breathe, the mother's there obviously upset, so the father's probably there and you're trying to get langoscope down their throat, it's not a great, it is a very stressful situation, so he's kind of developed a, trying to develop a better one, right? Even the simple things. These things are made of stainless steel and you put a piece of metal on a baby's tongue. A newborn baby's obviously never experienced cold before, so they obviously start freaking out and squirming and you're trying to get this thing down her throat. It's crazy. So I'm helping him to see if he can come up with a better solution. He's got a, got an idea at the moment. He's developed some prototypes and we're gonna help him get it, see if we can get it a bit further along, and hopefully get to the market and solve this real small unmet clinical need, but really important one. [00:19:16] Lindsey Dinneen: Yeah. That's incredible to hear about both of those stories. That is really exciting. I love I-- this is partly why I love this industry so much is the innovation coming out of it is always amazing. People care so deeply about making a difference and improving patient outcomes, and then to hear about those kinds of innovations, ugh, that's awesome. [00:19:38] Stuart Grant: Yeah. Yeah. So if there's any experts out there listening who wanna get involved in the N-H-S-C-E-P program, I know Australia does one too. So yeah, get involved and share your knowledge freely to some clinicians who wanna, who have found an unmet clinical need and wanna solve it, but don't know how to. [00:19:56] Lindsey Dinneen: Yeah. Love it. That's fantastic. So it, it seems like, you know, from your career trajectory and your continuing education all this time that you are not someone who sits still very well. And I think you mentioned this a little bit in your LinkedIn profile, you like to keep moving. So one of the things that I noticed that you do, and I'd love if you share about it, is you do lectures on the history of innovation. Could you share a little bit about that? [00:20:24] Stuart Grant: Yeah. So. I I really, so I sort of got into reading about innovate. I love reading innovation books, right, nonfiction, innovation books, which I got in about 10 years ago. I read probably one of the first one was "The Idea Factory," which is about Bell Labs. And that was how Bell Labs has invented the telephone system and invented the transistor, won a load of Nobel Prizes. Shockley and Bardine were there. They just had this crazy Medici effect going on in Bell Labs. The Medici effect when you collect everybody together in a small area and they just start bouncing ideas and coming up with some hugely creative solutions. And that comes from Florence when DaVinci and Michelangelo and Raphael were all kicking about Florence and they were all paid for by the Medici family, so this why it's called the Medici. There's a book about it actually called "The Medici Effect." So I started reading all this and started just going backwards in history and getting to the industrial revolution and how the industrial revolution happened. And going further back to these group of men called the Lunar Men who were in Birmingham here in the UK who basically, it was James Watt, who invented the steam engine, Wedgewood, who was the pottery guy. It is Rasmus Darwin, who was Charles Darwin's great-grandfather. Yeah. All these people, they were called the Lunar Man 'cause they met every month in the full moon and discussed ideas and I think probably got drunk. [00:22:00] Lindsey Dinneen: I mean... [00:22:03] Stuart Grant: So yeah, I just love reading it and you know, I love, I'm now a little bit of a brag. As of last month, I'm a fellow of the Institute of Mechanical Engineers, and that is quite prestigious that was created by George Stevenson, and George Stevenson was the guy who created the steam train. [00:22:23] Lindsey Dinneen: Okay. [00:22:23] Stuart Grant: So we took Watts' idea of the steam engine, put it on wheels, figured out how to work. And I love, I just love steam trains and that's very dorky of me, I know. But I love, as a mechanical engineer, just seeing all the bits move and actually seeing them chug around all the noise and the steam. And here where I live in Yorkshire, in the UK, up the road in York is the National Railway Museum, which all the steam trains are at. Darlington is west. George Stevenson had his the original railway, the Darton Stock Railway. So George Stevenson created the Institute of Mechanical Engineers 'cause he was a mechanical engineer and his son created the rocket the first really fast once, Robert Stevenson. So learning all this and then figuring out how, then I went back-- I'm, so this is a long answer to your question-- then I went back went back and like understood why the industrial revolution happened and it was all about the banking system here, how people could get capital. And then the legal system grew up to protect that capital. And then agriculture improved in the UK so people weren't just stuck on farms, subsistence farming. There was enough food being produced to support the population so the population could go and work in factories and obviously James Watt creating the steam power created more power. So people in horses and everybody didn't have to work so hard. And then there was politics involved with the Hugonos, which were the Protestant, the French Protestants came over and they had all, they had the ability to make all these machine parts, 'cause that's our skill. Some of them came to the UK and the others went to Switzerland. And that's where the watch industry in Switzerland created. And then, you know, and then the scientific approach and the enlightenment came in the UK and it all just sort of bubbled up into the industrial revolution and then cascaded through the 19th century and the 20th century in. Here we are in the 21st century. So I just love knowing that whole pathway of somebody said "We need more legal," and then somebody said, "We need more banking" and as startups, right, investment is the king. So it all started 300 years ago with the UK banking system. [00:24:35] Lindsey Dinneen: Fascinating. Oh my goodness. That is so interesting. Yeah. Okay. One other interesting thing I caught from your LinkedIn profile is that you are a painter, but you are an exhibited painter, yes? [00:24:51] Stuart Grant: Yeah, I, well, I try. [00:24:54] Lindsey Dinneen: Okay. [00:24:54] Stuart Grant: So yeah. Obviously I did product design right? And I did product design because at school, I was good at art and I was good at maths and physics. So I was looking around going, "What discipline do those three things fit together?" And it looked like it was product design. I was like, "Okay, I'm half an engineer, half an artist, not good at either." So about 10 years ago I decided to pick up art again. It was, started to go to classes and doing landscapes and actually sadly the industrial decline of Britain's, so the old buildings of the industrial revolution and stuff like that. So I paint that stuff. [00:25:36] Lindsey Dinneen: Oh, that's so cool. [00:25:37] Stuart Grant: Put it into exhibitions and sometimes get rejected, sometimes get accepted, and try and sell a couple so I can at least call myself an artist. [00:25:45] Lindsey Dinneen: There you go. I love it. Yeah. Well, and that creativity and that artistry does, you know, impact your work in general, because I think sometimes having that outlet actually spurs some just creative solutions outside of the box that, you know, might have not come to you immediately if you were just like, you know, head down, really working hard on this project. And then if you could take a step back do you feel that it helps you in that way at all? [00:26:15] Stuart Grant: Yeah. Yeah, it definitely does. Not thinking about work is and just having it percolate in the background and not actually, 'cause it's a very slow deliberate process painting, right? So it does, you just lose hours and hours painting something, which is really nice. Obviously I've got a, I've got a 5-year-old at the moment running around, so I don't do that much painting. I usually just reserve it for when I go to my art class on Wednesday nights 'cause trying to focus is not a thing for a 5-year-old. [00:26:46] Lindsey Dinneen: Yeah, That's fair. Okay. Well, all right, so pivoting the conversation just for fun. Imagine that you were to be offered a million dollars to teach a master class on anything you want. It could be within your industry. It also could be your history of innovation, but what would you choose to teach? [00:27:08] Stuart Grant: So I thought about this when you gave that question because I was like, "Well, I've already talked about the history of innovation and that can pretty boring." So my other boring side, when you do a PhD, you always wish you did another subject. That's the thing is like, I wish I studied that instead. So my, as you go through the PhD, you learn other things and you're like, "Oh, that's really interesting." And you go down rabbit holes and you're like, "Oh, well stop. That's not my job. That's not what I'm trying to do here." One of the ones was how technology and society are interlinked. So technology drives society, and we've got lots of examples of that. Steam engines, trains, telephones, electricity, light bulb, broadband, and now AI. And so technology affects society. Then society drives technology. They're a virtuous circle. Some people say it not virtuous at all, but they, that's what happens. And understanding how those two things, society and culture and technology all interact is really interesting to me. And obviously not all technologies are adopted. Some are abandoned. Sometimes the better technology is abandoned for an inferior technology for lots and lots of reasons. There's examples. In the eighties, it was VHS and beta max, Blu-ray and HD DVDs. And what else? The keyboard, QWERTY keyboard is meant to be terrible. And that was designed 'cause of typewriters at the time. So the keys didn't smash together, but obviously that's not needed anymore. So those things interest me and I like to study that more, but I like to study it. Thinking about medtech and how our technology in medtech has affected society and using that lens 'cause we also always talk about clinical needs, right? What's your unmet clinical need? What are you trying to solve here? But there's also a social and cultural need that you are maybe not addressing directly, but you are addressing it. And how that drives medtech, and you know, it's we talk about like medtech equality and democratizing medtech and making it more accessible, but there's always the flip size of medtech inequalities. The big one probably at the moment is robotic surgery. Hugely expensive. Only available to very few. So how will that filter through society? How does that affect society? Will it just be for the rich developed countries to use robotic surgery? How will that affect it going forward the next 10, 20 years? Because it uses a capital equipment, right? They can't be diffused through society very easily. So that, that's one thing I would like to study and sort of talk about a little bit more, 'cause I think it's really interesting, especially now AI is being talked about and how digitizing healthcare is gonna happen over the next decade. Interesting if we're overclaiming that at the moment and a lot of startups are overclaiming, what they can really do and is it gonna, is there gonna be a backlash? Who knows? Let's see. In our, maybe in a decade, I'll present a course on it. [00:30:23] Lindsey Dinneen: There you go. Okay. And time will tell. Alright. I like it. Very cool. Okay. And how do you wish to be remembered after you leave this world? [00:30:34] Stuart Grant: Yeah. My PhD was like, I would probably like, I'd like to remember my PhD findings, but I'm like, no, who cares? [00:30:44] Lindsey Dinneen: Oh. [00:30:45] Stuart Grant: I, I've got, of course, my family, making an impact on my, what I've done here with my family, but, and I was really thinking about this question earlier. I was like, "Well, I hope this isn't the end. I hope I haven't peaked." [00:31:02] Lindsey Dinneen: Yes, that's fair, okay. [00:31:06] Stuart Grant: So maybe the next 20, 30 years, hopefully I'll be remembered for something, I hope. [00:31:12] Lindsey Dinneen: Okay. To be determined. I like that. I like that a lot all right. [00:31:18] Stuart Grant: It's a positive. [00:31:20] Lindsey Dinneen: Yeah. It's, and it's a forward way of thinking that, you know, you don't have to limit yourself to what you've already done or accomplished or seen. Who knows? The world is exciting. Yeah. I like it. Okay. [00:31:33] Stuart Grant: Well, yes, I'm yeah, definitely. [00:31:35] Lindsey Dinneen: Yeah, all. [00:31:36] Stuart Grant: One of the things we're doing-- I was looking at the Australian MedTech market and really just trying to figure out what's going on to see if there's anything I can do there. And talking to my wife, we decided, 'cause my daughter's not at school yet, we decided, "Let's go to Australia for an extended holiday." And it was gonna be like a month and we'll start working it all out, like we're just gonna go for three months, March, April and May this year, to sort of experience Australia, experience the MedTech market, go meet a lot of people, understand and just sort of grow and try to understand another way of people. I know Australia, they've got a similar culture to the UK and the US. But they do, they are far away. So they have a different take on things. And I wanna see what a difference is and see if I can get involved. So we're off to Australia on the MedTech market, so if anybody's listening, reach out to me on LinkedIn. It'll be we'll hopefully when I'm over there, we are in Brisbane. We can meet up. [00:32:32] Lindsey Dinneen: Excellent. Yeah, no, that's really exciting. And I actually have a few people I can connect you with as well, so, yeah. Okay. And then final question. What is one thing that makes you smile every time you see or think about it? [00:32:48] Stuart Grant: Oh. I think it's, it is back to my old answers, it's back to the steam trains. I just love watching the mechanism going around. My, me and my daughter who's exhibiting engineering characteristics, shall we say. Love, we love going to the railway museum and running around 'cause you can go and touch the trains, you can get on them, you can get your hands greasy if you want to, if you touch the wrong bit of it. She loves seeing them. And they're just, so when these engineers designed all these big bits of metal, they didn't have FEA or CAD or anything. They just sort of took a guess at the curves and how it should look. And some of these parts they designed are so beautiful when you start looking at them, it just makes me smile, like there was a person, a man, we'll have to say a man, right, 'cause it was 200 years ago... [00:33:44] Lindsey Dinneen: Right. [00:33:44] Stuart Grant: A engineer who decided he was gonna make it like that out of wood. And they were cast into iron and they just they were just sitting in their shop and just did what they thought was right. And most of the time it didn't break. [00:34:00] Lindsey Dinneen: Most of the time. There you go. Yeah. That's great. I love that. Well this has really been a fantastic conversation. I'm so grateful for you joining me today and sharing just some of your history and you know, what you're looking forward to next. I think it's, I think it's really incredible when you get to combine all the different things, like you said. You've got sort of that design and problem solving and you've got the engineering and you've got all these cool things that just make you an incredible help to the MedTech industry. And we're excited to be making a donation on your behalf, as a thank you for your time today, to Sleep in Heavenly Peace, which provides beds for children who don't have any in the United States. So thank you for choosing that charity to support. Thanks for joining and thanks for everything you're doing to change lives for a better world. [00:34:52] Stuart Grant: Yeah, thanks, Lindsey. It's been a real pleasure talking to you. [00:34:55] Lindsey Dinneen: Yeah, absolutely. Thank you again. [00:35:00] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

CADENA 100 ofrece la mejor variedad musical. Desde Ankara, Turquía, llega la inspiradora iniciativa de empleados de limpieza que crean una biblioteca pública con libros recuperados de la basura. Un locutor comenta su lectura actual de "Reliquia" de Paul Was. Se celebra un récord Guinness: Joshua Sanders da 146 besos en la mejilla en 30 segundos. Ed Sheeran, que cumple 35 años, destaca la creación de su fundación para jóvenes talentos musicales. En 'Mateo & Andrea', Sonia de Villarreal gana un altavoz al identificar canciones de Imagine Dragons, Bombay y Pink. Jesús Ors arranca el jueves con música de David Guetta y Justin Timberlake. Finalmente, se aborda un documental de Take That, explorando la relación entre Gary Barlow y Robbie Williams y la posibilidad de una futura reunión.

What if robots could handle tedious retraction, precise bone milling, or even autonomous suturing, freeing surgeons to focus on complex decision-making and more patients?In this episode of the Succeed In Medicine Podcast, Dr. Bradley Block speaks with Dr. Michael Yip, as he explains that today's robots primarily serve as extensions of human surgeons via teleoperation (e.g., da Vinci for precision in hard-to-reach areas), enhancing dexterity, visualization, and accuracy rather than replacing them. He highlights existing autonomous applications in "hard tissue" procedures like the Mako or Stryker robots for precise bone milling in joint replacements, and non-contact examples like CyberKnife for focused radiation therapy.For soft tissue surgery, the more challenging domain due to tissue deformation and variability, autonomy is emerging in simpler, repetitive tasks such as retraction, suctioning, or basic suturing, with demonstrations dating back 15 years but real-world deployment lagging due to engineering, data, and economic hurdles. Dr. Yip discusses why demos in controlled settings don't easily translate to ORs, the shift to data-driven AI (with risks of out-of-distribution failures), and regulatory challenges like FDA expertise gaps and defining probabilistic safety. He predicts stepwise adoption: starting with assistant-level tasks (replacing med student/intern roles in retraction/suction), then progressing to free surgeons for higher-value work, especially in underserved rural areas via telesurgery. Full "skin-to-skin" autonomy (e.g., simple lipoma excision or appendectomy) remains years away, limited by hardware combining strength, dexterity, and precision in one system, though teams of specialized robots could accelerate progress. Ultimately, robotics will alleviate surgeon burnout from growing demand, not eliminate jobs soon.Three Actionable TakeawaysEmbrace Robotics Early in Training: Surgeons and trainees should gain hands-on experience with diverse robotic technologies now, treating them as essential tools that augment precision and dexterity rather than threats to obsolescence.Focus on Repetitive Tasks for Autonomy Gains: Prioritize robotic assistance in tedious, physically demanding steps like retraction, suctioning, or basic closure to free up time, reduce fatigue, and improve efficiency in high-volume or resource-limited settings.Stay Informed on Regulatory and Economic Shifts: Monitor evolving FDA guidelines for AI/surgical autonomy, economic incentives (e.g., cost savings in joint replacements or anastomosis), and liability frameworks to prepare for integration that enhances patient access and outcomes.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Michael Yip is an Associate Professor of Electrical and Computer Engineering at UC San Diego and Director of the Advanced Robotics and Controls Laboratory (ARCLab). His research focuses on surgical robots, biomimetic design, robot learning, autonomous robotic surgery, and deformable tissue manipulation. He has received the NSF CAREER Award, NIH Trailblazer Award, IEEE RAS Distinguished Lecturer recognition, and was named Faculty Innovator of the Year at UCSD in 2024 and elected to the National Academy of Inventors. Previously a Disney researcher at Amazon Robotics, he holds a BSc in Mechatronics Engineering from the University of Waterloo, MS in Electrical Engineering from the University of British Columbia, and PhD in Bioengineering from Stanford University.Website: yip.eng.ucsd.edu and ucsdarclab.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter   This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

CADENA 100 ofrece la mejor variedad musical. Se habla de un récord mundial fallido en Argentina, donde 2000 personas intentan flotar en el mar. Se escucha a Aitana con "Súper Estrella". Para las nuevas generaciones, el lujo es vivir cerca de todo, sin depender del coche y con tiempo libre. España aporta semillas de olivo al búnker global en Noruega. En 'Mateo & Andrea', unas invitadas de la serie "Valle Salvaje" juegan a adivinar canciones. El dúo Marlena visita la emisora para hablar de cómo gestionan el éxito, destacando su amistad y la importancia de sus fans. Un padre cuenta su ingenioso truco para que su hijo coma pescado. Jesús Ors presenta música de Coldplay, Tini, Juanes y Manuel Carrasco, mientras Belén de Vigo escucha haciendo manualidades con sus hijos.

¿Se puede vivir sin etiquetar todo como bueno o malo? Evaluar es necesario pero juzgar conduce al sufrimiento. Nos lo aclara nuestro maestro de meditación, Pablo d’Ors, que nos sigue ayudando a crear un jardín interior y que hoy escoge la palabra-semilla “juicio”. Concluimos este camino de vuelta con las historias de Alfonso Levy y nuestros oyentes; todos ellos caminantes tras la tormenta. Gracias por habitar este refugio sonoro de bienestar integral (RNE).Escuchar audio

CADENA 100 celebra el viernes 13 recordando la colocación del cartel de Hollywood y el lanzamiento de Super Mario Bros. 'Mateo & Andrea' presenta 45 minutos de música sin interrupción y juega a "Tu contra" con Ana de Ferrol, quien adivina a Manuel Carrasco, Abraham Mateo y Ana Mena. La emisora destaca su crecimiento y su rol como "la radio de Javi y Mar", ofreciendo 45 minutos de música cada hora. Se menciona contenido de '¡Buenos días, Javi y Mar!' disponible en podcast. Artistas como Lady Gaga, Amaral, Aitana y Ed Sheeran suenan en CADENA 100. Valeria Castro desea un feliz San Valentín. Jordi Sánchez, fundador de OBK, visita CADENA 100 para hablar de su nueva canción "Maldita mujer", su pasión por componer y los inicios de OBK. Jesús Ors acompaña a los oyentes con música y celebra el Día Mundial de la Radio, con temas como "Tacones Rojos" de Sebastián Yatra.

Un editor de cine comenta sobre las películas que optan a los Óscar, como *Hamnet*, y el tráiler de *Cumbres Borrascosas*, que llega por San Valentín. En CADENA 100 suena Aitana. Ricky Martin, tras la Super Bowl, desvela su secreto para la vitalidad. Bruno Mars bate récords de venta de entradas para su gira y estrena nuevo disco. En 'Mateo & Andrea', los oyentes participan en el juego "Tú contra Jessica" adivinando artistas como LP. La emisora destaca su crecimiento y artistas como Dani Fernández, Aitana, Nil Moliné, Lady Gaga, Benson Boone y Taylor Swift. La cantautora Valeria Castro felicita San Valentín. El dúo Marlena visita la emisora para hablar de la gestión del éxito y el apoyo de sus fans. Jesús Ors acompaña con 45 minutos de música sin interrupción, recordando éxitos como "Summer Love" de David Tavaré y el año 2006. CADENA 100 ofrece la mejor variedad musical y contenidos en su app y podcast.

CADENA 100 emite la mejor variedad musical y acompaña a sus oyentes con espacios como 'Mateo & Andrea'. En el programa, Erika de Valencia participa en "Tu contra Shazam" y gana un altavoz de la emisora al identificar "Feel" de Robbie Williams y "Shallow" de Lady Gaga. Aitana visita CADENA 100 para hablar de su "cuarto azul", sincerándose sobre su depresión y su postura ante la sobreexposición, incluyendo su negativa a participar en Eurovisión. La emisora destaca también el Día Mundial de las Legumbres y anuncia la programación de Jesús Ors con artistas como Adel y Manuel Turizo.

„Nézz már szét. Itt állunk a szeméttelep közepén, és gyógyszeres üvegeket kukázunk. Nem fogod vinni semmire.” Ezzel a mondattal indul a Másik út podcast harmadik epizódja, amelyben ezúttal Molnár Ferenc Caramellel beszélget Orsós Lajos. Húsz évvel azután, hogy egy ország mondott igent Caramelre – cigányok és nem cigányok együtt –, ez a beszélgetés már szükségszerűen túlmutat egyetlen életúton. Arra a kérdésre keres választ, mi változott meg körülöttünk azóta: a közös nyelvünkben, a társadalmi reflexeinkben. A beszélgetés nem a múltat akarja újramesélni, hanem azt próbálja megérteni, mit jelent ma a felemelkedés egy sokkal megosztottabb és óvatosabb közegben. Szó esik olyan, időtől és politikai zajtól független kérdésekről, amelyek minden korszakban meghatározóak: a munka, az esély, a felelősség, az elszakadás, a lojalitás, de szó esik arról az állapotról is, amikor az ember egyszerre tartozik két világhoz, ám egyik sem fogadja be teljesen. Hivatkozás masikut.hu Time: 01:18 – Ott nősz fel, ahol a világ kicsi, de az érzelmek nagyok. 03:40 – A telepen a zene a túlélési eszköze. 16:32 – Nem készülsz a győzelemre, ha egész életedben mást mondtak. 21:07 – Amikor az egész ország azt mondja egy cigánynak: kellesz. 35:22 – A felemelkedés ára: már sehol sem vagy igazán otthon.

Taylor Swift inspira a muchos jóvenes a visitar el museo de Wiesbaden, Alemania, para ver la pintura de Ofelia, gracias a su música sobre el personaje de Shakespeare. Una explosión solar promete auroras boreales en España, un fenómeno inusual que sorprende. Ed Sheeran se une a otros famosos como Mario Casas y Dani Martín que dejan el alcohol; él explica que, superados los 30, decide cuidarse al notar su menor resistencia en conciertos, mostrando un cambio físico asombroso. En 'Mateo & Andrea', Ana de Getafe gana un altavoz de CADENA 100 al identificar a Leire Martínez. Bruno Mars lanza un nuevo trabajo ocho años después de '24K Magic'; la espera ha creado gran expectación, y su gira es un éxito con fechas adicionales, incluyendo España. Jesús Ors presenta 45 minutos de música sin interrupción, con temas de Lala Love You, Sabrina Carpenter y el clásico 'Crazy' de Gnarls Barkley, además de complacer una petición de Maldita Nerea con Melendi para una oyente de Bilbao.

For years, parents have unknowingly trusted ORS bottles that didn't meet WHO guidelines, putting children's health at risk through excessive sugar content and misleading labels. What began as concern grew into a long, emotionally demanding fight for truth, transparency, and accountability in children's health products. In Season 5 of the Kidsstoppress Podcast, Mansi Zaveri, Founder of Kidsstoppress, is joined by paediatrician Dr. Sivaranjani Santosh to where she shares her story about her 8 year battle for ORS, the real impact of ORS misinformation, why correct Oral Rehydration Solution formulations matter, and how informed awareness can protect young lives. This powerful conversation reinforces why parents deserve honest information, clear labelling, and healthcare advice they can truly trust.Tune In NowSupport the show

Seguimos cultivando nuestro jardín interior con el prestigioso maestro de interioridad, Pablo d’Ors, colaborador de Tras la tormenta. La cuarta palabra (o semilla) que abordamos en esta temporada es el concepto de aceptación. Aceptar implica respetar y asumir. Aceptar –que no resignarse- nos cambia la perspectiva de la vida; nos lo explica Pablo con ejemplos cercanos. Comenzamos el camino con la historia inolvidable –y muy radiofónica- de dos hermanos caminantes tras la tormenta Escuchar audio

A magyar oktatási rendszer nem ott hibázik, hogy egyes gyerekek nem tanulnak meg időben olvasni vagy nem járnak rendszeresen iskolába. Ott bukik el, hogy úgy tesz, mintha minden gyerek ugyanabból a társadalmi valóságból érkezne, pedig nem. Lakhatási bizonytalanság, adósság, informális megélhetés között felnőni nem „hátrány”, hanem egy teljesen más logika szerint működő világ. Ebben a világban a hosszú távú tervezés és a szabálykövetés nem magától értetődő előny, hanem sokszor kockázat. Az iskola mégis ezekre épít, és aki nem hozza őket otthonról, az gyorsan kiesik. Az eredmény: az oktatás nem kiegyenlít, hanem szegregál. A jobb helyzetű családok gyerekei elhagyják az állami iskolákat, a hátrányos helyzetűek pedig koncentráltan maradnak a túlterhelt intézményekben. A rendszer működik, csak épp az egyenlőtlenséget termeli újra. Ezért félrevezető etnikai kérdésként beszélni a problémáról. A „roma gyerekek gondjai” nem identitásból, hanem szegénységből fakadnak. Ez strukturális állapot, ami ott jelenik meg, ahol az oktatás, a szociális ellátás és az egészségügy nem kapcsolódik össze. Erről szól ez az epizód, amelyben L. Ritók Nórával, az Igazgyöngy Alapítvány alapítójával beszélget Orsós Lajos, a Másik út platform alapítója. 0:18 Iskola: kapu vagy végállomás? 1:13 A szegénység alulértékelt valósága 1:49 Amikor az oktatás önmagában kevés 2:42 A „csak akarni kell” rendszerhazugság 3:35 Miért mindig a „könnyebb” réteget célozzák a programok? 6:21 Toldra nem hívtak, mégis maradnunk kellett 9:22 A rendszer vakfoltjai: ahol családok tűnnek el 10:22 Két világ logikája: túlélés vs. szabálykövetés 11:26 A fekete zóna: munka, uzsora, szolgáltatáshiány 13:22 Adósságcsapda és pénzügyi tudatlanság 23:31 Kiégő pedagógusok, szegregáló iskola 36:53 – Generációs szegénység: miért nincs gyors megoldás? Hivatkozás: masikut.hu

José Luna Borge, poeta, diarista, ensayista, nos habla de la poesía posterior a los novísimos, de Victor Botas, Miguel d'Ors, Eloy Sánchez Rosillo, José Luis García Martín, y también de su propia obra. Adelanta alguna novedad editorial que nos resulta muy interesante. Una conversación de quilates.

Hablamos de responsabilidad civil, derecho a la vivienda, duelo y literatura al hilo de Oxígeno (Ed. Alfaguara), la nueva novela de Marta Jiménez Serrano, en la que la autora se centra en el accidente que la dejó a las puertas de la muerte hace cinco años. Un suceso casi trágico que se prestaría a la crónica solemne y altisonante, pero que aquí está narrado con el pulso enérgico y preciso que ya es marca de la joven escritora madrileña.Además, Javier Lostalé abre su ventanita poética a La llama ebria. Antología de mujeres poetas del surrealismo (Ed. Bartleby), volumen coordinado y prologado por Lurdes Martínez que nos acerca a una constelación de creadoras de todo el mundo, tanto célebres como desconocidas, que ahora podemos leer en las traducciones de Eugenio Castro y Jesús García Rodríguez.Luego, Ignacio Elguero nos recomienda varias lecturas: Cruz del sur (Ed. Anagrama), el último libro de Claudio Magris, en el que el autor italiano sigue la pista a tres europeos que acabaron en lugares remotos, Tiempo de descuento (Ed. Pre-Textos) el nuevo poemario de Miguel D´Ors, de título muy revelador, y Flamenco y cante jondo (Ed. Reino de Cordelia), colección de artículos que el escritor y cineasta Edgar Neville dedicó a esta disciplina artística. También escuchamos al escritor y humorista Xavi Puig, protagonista de la sección de Sergio C. Fanjul con motivo de la publicación de Hacer reír (Ed. Debate), breve ensayo sobre el papel y la naturaleza de la sátira en el mundo contemporáneo que se funda en su experiencia al frente del medio satírico El mundo Today, del que es cofundador.Terminamos el programa Desmontando el poema con la ayuda de Mariano Peyrou, que hoy reivindica la faceta como poeta de Goethe, el clásico alemán, a raíz de la reciente publicación de Poemas esenciales (Ed. La oficina), una selección de su obra en verso con traducción de Helena Cortés Gabaudan.Escuchar audio

In this episode, the boys recap a CRAZY AFCON final, debating matchfixing allegations for Morocco, if Senegal should be penalized for leaving the pitch, as well as whether Ousmane Dembele can win back-to-back Ballon d'Ors, and where he ranks all-time in French history.

Allen, Joel, Rosemary, and Yolanda cover major offshore wind developments on both sides of the Atlantic. In the US, Ørsted’s Revolution Wind won a court victory allowing construction to resume after the Trump administration’s suspension. Meanwhile, the UK awarded contracts for 8.4 gigawatts of new offshore capacity in the largest auction in European history, with RWE securing nearly 7 gigawatts. Plus Canada’s Nova Scotia announces ambitious 40 gigawatt offshore wind plans, and the crew discusses the ongoing Denmark-Greenland tensions with the US administration. Sign up now for Uptime Tech News, our weekly newsletter on all things wind technology. This episode is sponsored by Weather Guard Lightning Tech. Learn more about Weather Guard’s StrikeTape Wind Turbine LPS retrofit. Follow the show on YouTube, Linkedin and visit Weather Guard on the web. And subscribe to Rosemary’s “Engineering with Rosie” YouTube channel here. Have a question we can answer on the show? Email us! The Uptime Wind Energy Podcast brought to you by Strike Tape, protecting thousands of wind turbines from lightning damage worldwide. Visit strike tape.com. And now your hosts, Alan Hall, Rosemary Barnes, Joel Saxon and Yolanda Padron. Welcome to the Uptime Wind Energy Podcast. I’m Allen Hall, along with Yolanda, Joel and Rosie. Boy, a lot of action in the US courts. And as you know, for weeks, American offshore wind has been holding its breath and a lot of people’s jobs are at stake right now. The Trump administration suspended, uh, five major projects on December 22nd, and still they’re still citing national security concerns. Billions of dollars are really in balance here. Construction vessels for most of these. Sites are just doing nothing at the minute, but the courts are stepping in and Sted won a [00:01:00] key victory when the federal judge allowed its revolution wind project off the coast of Rhode Island to resume construction immediately. So everybody’s excited there and it does sound like Osted is trying to finish that project as fast as they can. And Ecuador and Dominion Energy, which are two of the other bigger projects, are fighting similar battles. Ecuador is supposed to hear in the next couple of days as we’re recording. Uh, but the message is pretty clear from developers. They have invested too much to walk away, and if they get an opportunity to wrap these projects up quickly. They are going to do it now. Joel, before the show, we were talking about vineyard wind and vineyard. Wind was on hold, and I think it, it may not even be on hold right now, I have to go back and look. But when they were put on hold, uh, the question was, the turbines that were operating, were they able to continue operating? And the answer initially I thought was no. But it was yes, the, the turbines that were [00:02:00] producing power. We’re allowed to continue to produce powers. What was in the balance were the remaining turbines that were still being installed or, uh, being upgraded. So there’s, there’s a lot going on right now, but it does seem like, and back to your earlier point, Joel, before we start talking and maybe you can discuss this, we, there is an offshore wind farm called Block Island really closely all these other wind farms, and it’s been there for four or five years at this point. No one’s said anything about that wind farm.  Speaker: I think it’s been there, to be honest with you, since like 2016 or 17. It’s been there a long time. Is it that old? Yeah, yeah, yeah, yeah. So when we were talk, when we’ve been talking through and it gets lost in the shuffle and it shouldn’t, because that’s really the first offshore wind farm in the United States. We keep talking about all these big, you know, utility scale massive things, but that is a utility scale wind farm as well. There’s fi, correct me if I’m wrong, Yolanda, is it five turbos or six? It’s five. Their decent sized turbines are sitting on jackets. They’re just, uh, they’re, they’re only a couple miles offshore. They’re not way offshore. But throughout all of these issues that we’ve had, um, with [00:03:00] these injunctions and stopping construction and stopping this and reviewing permits and all these things, block Island has just been spinning, producing power, uh, for the locals there off the coast of Rhode Island. So we. What were our, the question was is, okay, all these other wind farms that are partially constructed, have they been spinning? Are they producing power? And my mind goes to this, um, as a risk reduction effort. I wonder if, uh, the cable, if the cable lay timelines were what they were. Right. So would you now, I guess as a risk reduction effort, and this seems really silly to have to think about this. If you have your offshore substation, was the, was the main export cable connected to some of these like revolution wind where they have the injunction right now? Was that export cable connected and were the inter array cables regularly connected to turbines and them coming online? Do, do, do, do, do. Like, it wasn’t like a COD, we turned the switch and we had to wait for all 62 turbines. Right. So to our [00:04:00] knowledge and, and, uh, please reach out to any of us on LinkedIn or an email or whatever to our knowledge. The turbines that are in production have still have been spinning. It’s the construction activities that have been stopped, but now. Hey, revolution wind is 90% complete and they’re back out and running, uh, on construction activities as of today. Speaker 2: It was in the last 48 hours. So this, this is a good sign because I think as the other wind farms go through the courts, they’re gonna essentially run through this, this same judge I that. Tends to happen because they have done all the research already. So you, you likely get the same outcome for all the other wind farms, although they have to go through the process. You can’t do like a class action, at least that’s doesn’t appear to be in play at the minute. Uh, they’re all gonna have to go through this little bit of a process. But what the judge is saying essentially is the concern from the Department of War, and then the Department of Interior is. [00:05:00] Make believe. I, I don’t wanna frame it. It’s not framed that way, the way it’s written. There’s a lot more legalistic terms about it. But it basically, they’re saying they tried to stop it before they didn’t get the result they wanted. The Trump administration didn’t get the result they wanted. So the Trump administration ramped it up by saying it was something that was classified in, in part of the Department of War. The judge isn’t buying it. So the, the, the early action. I think what we initially talked about this, everybody, I think the early feeling was they’re trying to stop it, but the fact that they’re trying to stop it just because, and just start pulling permits is not gonna stand outta the court. And when they want to come back and do it again, they’re not likely to win. If they would. Kept their ammunition dry and just from the beginning said it’s something classified as something defense related that Trump administration probably would’ve had a better shot at this. But now it just seems like everything’s just gonna lead down the pathway where all these projects get finished. Speaker: Yeah, I think that specific judge probably was listening to the [00:06:00] Uptime podcast last week for his research. Um, listen to, to our opinions that we talked about here, saying that this is kind of all bs. It’s not gonna fly. Uh, but what we’re sitting at here is like Revolution Wind was, had the injunction against it. Uh, empire Wind had an injunction again, but they were awaiting a similar ruling. So hopefully that’s actually supposed to go down today. That’s Wednesday. Uh, this is, so we’re recording this on Wednesday. Um, and then Dominion is, has, is suing as well, and their, uh, hearing is on Friday. In two, two days from now. And I would expect, I mean, it’s the same, same judge, same piece of papers, like it’s going to be the same result. Some numbers to throw at this thing. Now, just so the listeners know the impact of this, uh, dominion for the Coastal Virginia Offshore Wind Project, they say that their pause in construction is costing them $5 million a day, and that is. That’s a pretty round number. It’s a conservative number to be honest with you. For officer operations, how many vessels and how much stuff is out there? That makes sense. Yep. [00:07:00] 5 million. So $5 million a day. And that’s one of the wind farms. Uh, coastal, Virginia Wind Farm is an $11 billion project. With, uh, it’s like 176 turbines. I think something to that, like it’s, it’s got enough power, it’s gonna have enough production out there to power up, like, uh, like 650,000 homes when it’s done. So there’s five projects suspended right now. I’m continuing with the numbers. Um, well, five, there’s four now. Revolution’s back running, right? So five and there’s four. Uh, four still stopped. And of those five is 28. Billion dollars in combined capital at risk, right? So you can understand why some of these companies are worried, right? They’re this is, this is not peanuts. Um, so you saw a little bump in like Ted stock in the markets when this, this, uh, revolution wind, uh, injunction was stopped. Uh, but. You also see that, uh, Moody’s is a credit [00:08:00] rating. They’ve lowered ORs, Ted’s um, rating from stable to negative, given that political risk.  Speaker 2: Well, if you haven’t been paying attention, wind energy O and m Australia 2026 is happening relatively soon. It’s gonna be February 17th and 18th. It’s gonna be at the Pullman Hotel downtown Melbourne. And we are all looking forward to it. The, the roster and the agenda is, is nearly assembled at this point. Uh, we have a, a couple of last minute speakers, but uh, I’m looking at the agenda and like, wow, if you work in o and m or even are around wind turbines, this is the place to be in February. From my  Speaker: seat. It’s pretty, it’s, it’s, it’s shaping up for pretty fun. My phone has just been inundated with text message and WhatsApp of when are you traveling? What are your dates looking forward to, and I wanna say this right, Rosie. Looking forward to Melvin. Did I get it? Did I do it okay.  Speaker 3: You know how to say it.  Speaker: So, so we’re, we’re really looking forward to, we’ve got a bunch of people traveling from around the [00:09:00] world, uh, to come and share their collective knowledge, uh, and learn from the Australians about how they’re doing things, what the, what the risks are, what the problems are, uh, really looking forward to the environment down there, like we had last year was very. Collaborative, the conversations are flowing. Um, so we’re looking forward to it, uh, in a big way from our seats. Over here,  Speaker 2: we are announcing a lightning workshop, and that workshop will be answering all your lightning questions in regards to your turbines Now. Typically when we do this, it’s about $10,000 per seat, and this will be free as part of WMA 2026. We’re gonna talk about some of the lightning physics, what’s actually happening in the field versus what the OEMs are saying and what the IEC specification indicates. And the big one is force majeure. A lot of operators are paying for damages that are well within the IEC specification, and we’ll explain.[00:10:00] What that is all about and what you can do to save yourself literally millions of dollars. But that is only possible if you go to Woma 2020 six.com and register today because we’re running outta seats. Once they’re gone, they’re gone. But this is a great opportunity to get your lightning questions answered. And Rosemary promised me that we’re gonna talk about Vestus turbines. Siemens turbines. GE Renova turbines. Nordex turbines. So if you have Nordex turbines, Sulan turbines, bring the turbine. Type, we’ll talk about it. We’ll get your questions answered, and the goal is that everybody at at Wilma 2026 is gonna go home and save themselves millions of dollars in 26 and millions of dollars in 27 and all the years after, because this Lightning workshop is going to take care of those really frustrating lightning questions that just don’t get answered. We’re gonna do it right there. Sign up today.  Speaker 3: [00:11:00] You know what, I’m really looking forward to that session and especially ’cause I’ve got a couple of new staff or new-ish staff at, it’s a great way to get them up to speed on lightning. And I think that actually like the majority of people, even if you are struggling with lightning problems every day, I bet that there is a whole bunch that you could learn about the underlying physics of lightning. And there’s not so many places to find that in the world. I have looked, um, for my staff training, where is the course that I can send them to, to understand all about lightning? I know when I started atm, I had a, an intro session, one-on-one with the, you know, chief Lightning guy there. That’s not so easy to come by, and this is the opportunity where you can get that and better because it’s information about every, every OEM and a bit of a better understanding about how it works so that you can, you know, one of the things that I find working with Lightning is a lot of force MA mature claims. And then, um, the OEMs, they try and bamboozle you with this like scientific sounding talk. If you understand better, then you’ll be able to do better in those discussions. [00:12:00] So I would highly recommend attending if you can swing the Monday as well.  Speaker: If you wanna attend now and you’re coming to the events. Reach out to, you can reach out to me directly because what we want to do now is collect, uh, as much information as possible about the specific turbine types of the, that the people in the room are gonna be responsible for. So we can tailor those messages, um, to help you out directly. So feel free to reach out to me, joel.saxo, SAXU m@wglightning.com and uh, we’ll be squared away and ready to roll on Monday. I think that’s Monday the 16th.  Speaker 2: So while American offshore wind fights for survival in the courts, British offshore wind just had its biggest day ever. The United Kingdom awarded contracts for 8.4 gigawatts. That’s right. 8.4 gigawatts of new offshore wind capacity, the largest auction in European history. Holy smokes guys. The price came in at about 91 pounds per megawatt hour, and that’s 2024 pounds. [00:13:00] Uh, and that’s roughly 40% cheaper than building a new. Gas plant Energy Secretary Ed Milliband called it a monumental step towards the country’s 2030 clean power goals and that it is, uh, critics say that prices are still higher than previous auctions, and one that the government faces challenges connecting all this new capacity to the grid, and they do, uh, transmission is a limiting factor here, but in terms of where the UK is headed. Putting in gigawatts of offshore wind is going to disconnect them from a lot of need on the gas supply and other energy sources. It’s a massive auction round. This was way above what I remember being, uh. Talked about when we were in Scotland just a couple of weeks ago, Joel.  Speaker: Yeah, that’s what I was gonna say. You know, when we were, when we were up with the, or E Catapult event, and we talked to a lot of the different organizations of their OWGP and um, you know, the course, the or e Catapult folks and, and, and a [00:14:00] few others, they were really excited about AR seven. They were like, oh, we’re, we’re so excited. It’s gonna come down, it’s gonna be great. I didn’t expect these kind of numbers to come out of this thing. Right? ’cause we know that, um, they’ve got about, uh, the UK currently has about. 16 and a half or so gigawatts of offshore wind capacity, um, with, you know, they got a bunch under construction, it’s like 11 under construction, but their goal is to have 43 gigawatts by 2030. So,  Speaker 2: man.  Speaker: Yeah. And, and when 2030, put this into Conte Con context now. This is one of our first podcasts of the new year. That’s only four years away. Right. It’s soon. And, and to, to be able to do that. So you’re saying they got 16, they go some round numbers. They got 16 now. Pro producing 11 in the pipe, 11 being constructed. So get that to 27. That’s another 16 gigawatts of wind. They want, they that are not under construction today that they want to have completed in the next four years. That is a monumental effort now. We know that there’s some grid grid complications and connection [00:15:00] requirements and things that will slow that down, but just thinking about remove the grid idea, just thinking about the amount of effort to get those kind of large capital projects done in that short of timeline. Kudos to the UK ’cause they’re unlocking a lot of, um, a lot of private investment, a lot of effort to get these things, but they’re literally doing the inverse of what we’re doing in the United States right now.  Speaker 2: There would be about a total of 550, 615 ish megawatt turbines in the water. That does seem doable though. The big question is who’s gonna be providing those turbines? That’s a. Massive order. Whoever the salesperson is involved in that transaction is gonna be very happy. Well, the interesting thing here  Speaker: too is the global context of assets to be able to deliver this. We just got done talking about the troubles at these wind farms in the United States. As soon as these. Wind farms are finished. There’s not more of them coming to construction phase shortly, right? So all of these assets, all these jack up vessels, these installation vessels, these specialized cable lay vessels, they [00:16:00]can, they can fuel up and freaking head right across, back across the Atlantic and start working on these things. If the pre all of the engineering and, and the turbine deliveries are ready to roll the vessels, uh, ’cause that you, that, you know, two years ago that was a problem. We were all. Forecasting. Oh, we have this forecasted problem of a shortage of vessels and assets to be able to do installs. And now with the US kind of, basically, once we’re done with the wind farms, we’re working on offshore, now we’re shutting it down. It frees those back up, right? So the vessels will be there, be ready to roll. You’ll have people coming off of construction projects that know what’s going on, right? That, that know how to, to work these things. So the, the people, the vessels that will be ready to roll it is just, can we get the cables, the mono piles, the turbines and the cells, the blades, all done in time, uh, to make this happen And, and. I know I’m rambling now, but after leaving that or e Catapult event and talking to some of the people, um, that are supporting those [00:17:00] funds over there, uh, being injected from the, uh, the government, I think that they’ve got  Speaker 2: the, the money flowing over there to get it done too. The big winner in the auction round was RWE and they. Almost seven gigawatts. So that was a larger share of the 8.4 gigawatts. RWE obviously has a relationship with Vestus. Is that where this is gonna go? They’re gonna be, uh, installing vestus turbines. And where were those tur turbines? As I was informed by Scottish gentlemen, I won’t name names. Uh, will those turbines be built in the uk? Speaker 3: It’s a lot. It’s a, it’s one of the biggest challenges with, um, the supply chain for wind energy is that it just is so lumpy. So, you know, you get, um, uh. You get huge eight gigawatts all at once and then you have years of, you know, just not much. Not much, not much going on. I mean, for sure they’re not gonna be just building [00:18:00] eight gigawatts worth of, um, wind turbines in the UK in the next couple of years because they would also have to build the capacity to manufacture that and, and then would wanna be building cocks every couple of years for, you know, the next 10 or 20 years. So, yeah, of course they’re gonna be manufacturing. At facilities around the world and, and transporting them. But, um, yeah, I just, I don’t know. It’s one of the things that I just. Constantly shake my head about is like, how come, especially when projects are government supported, when plans are government supported, why, why can’t we do a better job of smoothing things out so that you can have, you know, for example, local manufacturing because everyone knows that they’ve got a secure pipeline. It’s just when the government’s involved, it should be possible.  Speaker 2: At least the UK has been putting forth some. Pretty big numbers to support a local supply chain. When we were over in Scotland, they announced 300 million pounds, and that was just one of several. That’s gonna happen over the next year. There will be a [00:19:00] near a billion pounds be put into the supply chain, which will make a dramatic difference. But I think you’re right. Also, it’s, they’re gonna ramp up and then they, it’s gonna ramp down. They have to find a way to feed the global marketplace at some point, be because the technology and the people are there. It’s a question of. How do you sustain it for a 20, 30 year period? That’s a different question. Speaker 3: I do agree that the UK is doing a better job than probably anybody else. Um, it it’s just that they, the way that they have chosen to organize these auctions and the government support and the planning just means that they have that, that this is the perfect conditions to, you know. Make a smooth rollout and you know, take care of all this. And so I just a bit frustrated that they’re not doing more. But you are right that they’re doing the best probably  Speaker 4: once all of these are in service though, aren’t there quite a bit of aftermarket products that are available in the UK  Speaker: on the service then? I think there’s more.  Speaker 4: Which, I mean, that’s good. A good part of it, right? Speaker: If we’re talking Vestas, so, so let’s just round this [00:20:00] up too. If we’re talking vest’s production for blades in Europe, you have two facilities in Denmark that build V 2 36 blades. You have one facility in Italy that builds V 2 36 blades, Taiwan, but they build them for the APAC market. Of course. Um, Poland had a, has one on hold right now, V 2 36 as well. Well, they just bought that factory from LM up in Poland also. That’s, but I think that’s for onshore term, onshore blades. Oh, yes, sure. And then Scotland has, they have the proposed facility in, in Laith. That there, that’s kind of on hold as well. So if that one’s proposed, I’m sure, hey, if we get a big order, they’ll spin that up quick because they’ll get, I am, I would imagine someone o you know, one of the, one of the funds to spool up a little bit of money, boom, boom, boom. ’cause they’re turning into local jobs. Local supply  Speaker 2: chain does this then create the condition where a lot of wind turbines, like when we were in Scotland, a lot of those wind turbines are. Gonna reach 20 years old, maybe a little bit older here over the next five years where they will [00:21:00] need to be repowered upgraded, whatever’s gonna happen there. If you had internal manufacturing. In country that would, you’d think lower the price to go do that. That will be a big effort just like it is in Spain right now.  Speaker: The trouble there though too, is if you’re using local content in, in the uk, the labor prices are so much  Speaker 2: higher. I’m gonna go back to Rosie’s point about sort of the way energy is sold worldwide. UK has high energy prices, mostly because they are buying energy from other countries and it’s expensive to get it in country. So yes, they can have higher labor prices and still be lower cost compared to the alternatives. It, it’s not the same equation in the US versus uk. It’s, it’s totally different economics, but. If they get enough power generation, which I think the UK will, they’re gonna offload that and they’re already doing it now. So you can send power to France, send power up [00:22:00] north. There’s ways to sell that extra power and help pay for the system you built. That would make a a lot of sense. It’s very similar to what the Saudis have done for. Dang near 80 years, which is fill tankers full of oil and sell it. This is a little bit different that we’re just sending electrons through the water to adjacent European countries. It does seem like a plan. I hope they’re sending ’em through a cable in the water and not just into the water. Well, here’s the thing that was concerning early on. They’re gonna turn it into hydrogen and put it on a ship and send it over to France. Like that didn’t make any sense at all. Uh. Cable’s on the way to do it. Right.  Speaker: And actually, Alan, you and I did have a conversation with someone not too long ago about that triage market and how the project where they put that, that that trans, that HVDC cable next to the tunnel it, and it made and it like paid for itself in a year or something. Was that like, that they didn’t wanna really tell us like, yeah, it paid for itself in a year. Like it was a, the ROI was like on a, like a $500 million [00:23:00]project or something. That’s crazy. Um, but yeah, that’s the same. That’s, that is, I would say part of the big push in the uk there is, uh, then they can triage that power and send it, send it back across. Um, like I think Nord Link is the, the cable between Peterhead and Norway, right? So you have, you have a triage market going across to the Scandinavian countries. You have the triage market going to mainland eu. Um, and in when they have big time wind, they’re gonna be able to do it. So when you have an RWE. Looking at seven gigawatts of, uh, possibility that they just, uh, just procured. Game on. I love it. I think it’s gonna be cool. I’m, I’m happy to see it blow  Speaker 2: up. Canada is getting serious about offshore wind and international developers are paying attention. Q Energy, France and its South Korean partner. Hawa Ocean have submitted applications to develop wind projects off Nova Scotia’s Coast. The province has big ambitions. Premier, Tim Houston wants to license enough. Offshore [00:24:00] wind to produce 40 gigawatts of power far more than Nova Scotia would ever need. Uh, the extra electricity could supply more than a quarter of Canada’s total demand. If all goes according to plan, the first turbines could be spinning by 2035. Now, Joel. Yeah, some of this power will go to Canada, but there’s a huge market in the United States also for this power and the capacity factor up in Nova Scotia offshore is really good. Yeah. It’s uh, it  Speaker: is simply, it’s stellar, right? Uh, that whole No, Nova Scotia, new Brunswick, Newfoundland, that whole e even Maritimes of Canada. The wind, the wind never stops blowing, right? Like I, I go up there every once in a while ’cause my wife is from up there and, uh, it’s miserable sometimes even in the middle of summer. Um, so the, the wind resource is fantastic. The, it, it is a boom or will be a boom for the Canadian market, right? There’re always [00:25:00] that maritime community, they’re always looking for, for, uh, new jobs. New jobs, new jobs. And this is gonna bring them to them. Um, one thing I wanna flag here is when I know this, when this announcement came out. And I reached out to Tim Houston’s office to try to get him on the podcast, and I haven’t gotten a response yet. Nova Scotia. So if someone that’s listening can get ahold of Tim Houston, we’d love to talk to him about the plans for Nova Scotia. Um, but, but we see that just like we see over overseas, the triage market of we’re making power, we can sell it. You know, we balance out the prices, we can sell it to other places. From our seats here we’ve been talking about. The electricity demand on the east coast of the United States for, for years and how it is just climbing, climbing, climbing, especially AI data centers. Virginia is a hub of this, right? They need power and we’re shooting ourselves in the foot, foot for offshore wind, plus also canceling pipelines and like there’s no extra generation going on there except for some solar plants where you can squeeze ’em in down in the Carolinas and whatnot. [00:26:00] There is a massive play here for the Canadians to be able to HVD see some power down to us. Speaker 2: The offshore conditions off the coast of Nova Scotia are pretty rough, and the capacity factor being so high makes me think of some of the Brazilian wind farms where the capacity factor is over 50%. It’s amazing down there, but one of the outcomes of that has been early turbine problems. And I’m wondering if the Nova Scotia market is going to demand a different kind of turbine that is specifically built for those conditions. It’s cold, really cold. It’s really windy. There’s a lot of moisture in the air, right? So the salt is gonna be bad. Uh, and then the sea life too, right? There’s a lot of, uh, sea life off the coast of the Nova Scotia, which everybody’s gonna be concerned about. Obviously, as this gets rolling. How do we think about this? And who’s gonna be the manufacturer of turbines for Canada? Is it gonna be Nordics? Well,  Speaker: let’s start from the ground up there. So from the or ground up, it’s, how about sea [00:27:00] floor up? Let’s start from there. There is a lot of really, really, if you’ve ever worked in the offshore world, the o offshore, maritime Canadian universities that focus on the, on offshore construction, they produce some of the best engineers for those markets, right? So if you go down to Houston, Texas where there’s offshore oil and gas companies and engineering companies everywhere, you run into Canadians from the Maritimes all over the place ’cause they’re really good at what they do. Um, they are developing or they have developed offshore oil and gas platforms. Off of the coast of Newfoundland and up, up in that area. And there’s some crazy stuff you have to compete with, right? So you have icebergs up there. There’s no icebergs in the North Atlantic that like, you know, horn seats, internet cruising through horn C3 with icebergs. So they’ve, they’ve engineered and created foundations and things that can deal with that, those situations up there. But you also have to remember that you’re in the Canadian Shield, which is, um, the Canadian Shield is a geotechnical formation, right? So it’s very rocky. Um, and it’s not [00:28:00] like, uh, the other places where we’re putting fixed bottom wind in where you just pound the piles into the sand. That’s not how it’s going to go, uh, up in Canada there. So there’s some different engineering that’s going to have to take place for the foundations, but like you said, Alan Turbine specific. It blows up there. Right. And we have seen onshore, even in the United States, when you get to areas that have high capacity burning out main bearings, burning out generators prematurely because the capacity factor is so high and those turbines are just churning. Um, I, I don’t know if any of the offshore wind turbine manufacturers are adjusting any designs specifically for any markets. I, I just don’t know that. Um, but they may run into some. Some tough stuff up there, right? You might run into some, some overspeeding main bearings and some maintenance issues, specifically in the wintertime ’cause it is nasty up there. Speaker 2: Well, if you have 40 gigawatts of capacity, you have several thousand turbines, you wanna make sure really [00:29:00] sure that the blade design is right, that the gearbox is right if you have a gearbox, and that everything is essentially over-designed, heated. You can have deicing systems on it, I would assume that would be something you would be thinking about. You do the same thing for the monopoles. The whole assembly’s gotta be, have a, just a different thought process than a turbine. You would stick off the coast of Germany. Still rough conditions at times, but not like Nova Scotia.  Speaker: One, one other thing there to think about too that we haven’t dealt with, um. In such extreme levels is the, the off the coast of No. Nova Scotia is the Bay of Fundee. If you know anything about the Bay of Fundee, it is the highest tide swings in the world. So the tide swings at certain times of the year, can be upwards of 10 meters in a 12 hour period in this area of, of the ocean. And that comes with it. Different time, different types of, um, one of the difficult things for tide swings is it creates subsid currents. [00:30:00] Subsid currents are, are really, really, really bad, nasty. Against rocks and for any kind of cable lay activities and longevity of cable lay scour protection around turbines and stuff like that. So that’s another thing that subsea that we really haven’t spoke about.  Speaker 3: You know, I knew when you say Bay Bay of funding, I’m like, I know that I have heard that place before and it’s when I was researching for. Tidal power videos for Tidal Stream. It’s like the best place to, to generate electricity from. Yeah, from Tidal Stream. So I guess if you are gonna be whacking wind turbines in there anyway, maybe you can share some infrastructure and Yeah. Eca a little bit, a little bit more from your, your project.  Speaker 2: that wraps up another episode of the Uptime Wind Energy Podcast. If today’s discussion sparked any questions or ideas. We’d love to hear from you. Just reach out to us on LinkedIn and don’t forget to subscribe so you never miss an episode. And if you found value in today’s conversation, please leave us a review. It really helps other wind energy professionals discover the show For Rosie, Yolanda and Joel, I’m Alan Hall, and we’ll see you here next week on the Uptime [00:36:00] Wind Energy Podcast.

Después de nuestro curso de meditación, nos disponemos a cultivar nuestro jardín interior aprendiendo varios conceptos. El sacerdote y escritor Pablo d'Ors nos propone profundizar en la idea de "sabiduría"; ¿qué es? ¿sufrimos porque no sabemos? ¿qué necesitamos aprender? Continuamos nuestro camino tras la tormenta con Rafael Álvarez "El Brujo" que ha llevado al teatro el célebre libro Autobiografía de un yogui. Nuestro contador de historias, Alfonso Levy, nos acerca a una figura de la que aprender, la ecologista Rachel Carson.Escuchar audio

A Másik út podcastben arról beszélünk, ami Magyarországon mindenkit érint, de amiről ritkán beszélünk őszintén: miért érezzük azt egyre többen, hogy nem működik a rendszer, miért fáradtak el az emberek, miért nő a düh, a kiégés, a kilátástalanság – és miért nem segítenek már a megszokott válaszok. A szegénység világát próbáljuk bemutatni belülről és olyan emberekkel gondolkozni közösen, akik valamilyen formában értik, megfigyelik, megélik ennek a világnak a mindennapjait. Az első epizód vendége Pogátsa Zoltán közgazdász, szociológus. A műsor vezetője pedig Orsós Lajos, a Másik út platform alapítója. Szó lesz gazdaságról, társadalmi feszültségekről, felelősségről, és arról, hogy mit jelent ma Magyarországon „normálisan élni”. Ez a beszélgetés nem lesz megnyugtató, nem ad gyors válaszokat, viszont segít jobban érteni, hogy hol tartunk – és miért itt. yt time: 00:00 – „Mi lett a középosztállyal Magyarországon? 01:10 – Mi lesz, ha nem építünk ki egy közös nyelvet? 04:20 – Mit jelent ma szegénynek lenni? 08:55 – A magyar paradoxon: mindenki középosztálybelinek hiszi magát. 13:30 – Hogy lesz egy társadalom szegény? 18:05 – Jó, ha van lóvé, de mire használjuk? 27:50 – Rendszerváltás: amikor egy ország alatt kihúzták a talajt. 36:10 – Roma kérdés újraértelmezve: miért zsákutca az etnikai magyarázat? 43:00 – „A legtöbb szegény nem roma, de a legtöbb roma szegény.” Mi következik ebből? 52:30 – Oktatás, egészség, nyelv: itt dől el minden, de nem történik semmi 01:04:30 – Ambícióhorizont: meddig mer álmodni egy szegény gyerek? 01:17:00 – Ha nincs kiút, de van harag, identitáspolitika, erőszak – mi jön ezután? 01:26:40 – Zárás: humántőke vagy szétesés. Harmadik út nincs.

Zum Gewinnspiel: Hier entlangWie Ihr teilnehmt: Einfach über den Link in der Bio in den Shop gehen, Buch aussuchen, Autor:in und Buchtitel in die Kommentare posten.. Wählen könnt Ihr aus allen, im Shop verfügbaren Bänden der blauen ‚NomosLehrbuch‘-Reihe. Ihr könnt pro Folge einmal in den Lostopf kommen. Also sucht auch nach den restlichen Gewinnspielhinweisen in den nächsten Folgen! Viel Glück und schöne Vorweihnachtszeit! Folgenbeschreibung:Das Kammergericht Berlin entschied, dass das Festkleben auf der Straße mit Sekundenkleber einen Widerstand gegen Vollstreckungsbeamte nach § 113 StGB darstellt. Der verwendete Sekundenkleber sei ein materielles Zwangsmittel, das Adhäsionskräfte erzeuge. Die mittelbare Kraftentfaltung wirke im Zeitpunkt der Vollstreckungshandlung, da der Polizeibeamte seine Diensthandlung nur unter Einsatz von Hilfsmitteln ausführen könne. Das KG wendet sich gegen die Gegenposition des OLG Dresden, wonach nur "kraftverstärkende" feste Hilfsmittel (wie Trennschleifer) Gewalt darstellen, nicht aber die Verwendung von Lösungsmitteln. Entscheidend sei die Adhäsionskraft, nicht die Art ihrer Überwindung. Die Folge behandelt den Gewaltbegriff des § 113 StGB, mehraktige Tatgeschehen, § 113 als unechtes Unternehmensdelikt und die hochaktuelle Klausurrelevanz des Festklebe-Problems.Entscheidung: KG Berlin, Urt. v. 2.6.2025 – 3 ORs 22/25, NStZ 2025, 737Support the show

En Tras la tormenta (RNE) os invitamos a una edición especial con motivo de las vacaciones de Navidad. Recordamos algunas de las enseñanzas del gran maestro de interioridad, Pablo d’Ors, y releemos libros que apuestan por el autocuidado. Gracias por formar parte de este camino donde el bienestar emocional fomenta la salud mental. ¡Feliz descanso de Navidad! Escuchar audio

CADENA 100 ofrece la mejor variedad musical. Nil Moliner confiesa no recordar sus conciertos intensos, mientras su tema "Tu cuerpo en braille" suena. David Guetta, DJ número uno mundial, lanza nuevas colaboraciones. En 'Mateo & Andrea', Fran gana un altavoz de CADENA 100 al acertar canciones de Álvaro Soler y Jennifer López, Nicki Minaj y Maná. El programa también acompaña a Dela, quien agradece la sintonía. '¡Buenos días, Javi y Mar!' desean feliz Navidad. Se destaca la historia de Taylor Swift, quien supera su miedo a bailar con esfuerzo y confianza, consolidándose como artista completa. Jesús Ors ameniza la noche con música de Madonna, Miley Cyrus y Coldplay. Finalmente, se anuncian las nuevas fechas de la gira "La Insurrección" de Dani Fernández y Yarea en Valencia y Madrid.

Send us a textStep into the magical world of football legends with this special episode of Soccer Bedtime Stories, featuring Ronaldo Luís Nazário de Lima — the original Ronaldo, known around the globe as O Fenômeno.Before he lit up the World Cup, before the Ballon d'Ors and breathtaking goals, Ronaldo was a quiet boy weaving through the narrow streets of Bento Ribeiro, Brazil. In this calming, family-friendly bedtime story, we trace the breathtaking rise of one of the greatest footballers of all time.⚽ What you'll hear in this episode:Ronaldo's childhood in Rio, juggling dreams and povertyHis incredible 166-goal futsal season that amazed scoutsEarly pro days at Cruzeiro, breaking records and expectationsElectric moves at PSV Eindhoven, Barcelona, and Inter MilanThe heartbreak of the 1998 World Cup and the mystery surrounding itHis legendary comeback at the 2002 FIFA World Cup, winning the Golden BootHow Ronaldo redefined what it means to be a Number 9Whether you're a parent looking for inspiring soccer stories for your child, a young fan curious about the greats, or a football lover who remembers Ronaldo's magic firsthand — this episode is for you." Modern strikers still live in his shadow. Messi grew up watching him. Ibrahimović calls him the most complete forward ever. Strikers like Benzema, Agüero, and Lukaku talk about how he changed what it meant to be a number 9. Before Ronaldo, a center-forward was often seen as a poacher, a finisher who lived mainly in the penalty box. Ronaldo dropped deep, dribbled past entire teams, sprinted like a winger, and finished like a sniper. He was strong enough to hold off defenders, fast enough to leave them behind, and calm enough to make the hardest finish look like a training exercise. "

El prestigioso maestro de meditación, Pablo d’Ors, nos conduce a la segunda parada de este gran viaje interior que propone en Tras la tormenta (RNE). Después de abordar el concepto de “interioridad”, nos aproximarnos al término de “consciencia”. ¿Cómo podríamos definirla? ¿Con qué nos identificamos? ¿Qué somos? Pablo nos hace reflexionar sobre nuestra comprensión de la realidad y nos propone preguntas prácticas al final de la sesión. Además, escuchamos las impresiones de nuestros oyentes, “caminantes tras la tormenta”.Escuchar audio

In today's episode on 25th November 2025, we explain how sugary drinks are finally banned from calling themselves ORS and why it took so long for the ban to finally be implemented on all energy drinks, ready-to-serve drinks and electrolyte beverages.30 minutes is all it takes to secure your family's future with Ditto's expert insurance advice. ⁠⁠Book a FREE call today and we promise no spam or forced selling.⁠

Ask for ORS at your local pharmacy and odds are you will be handed a tetrapack of ORSL or some other liquids that may have the letters ORS on their packaging but are not actually the formulations recommended by the World Health Organization. ORS or oral rehydration salts are a vital formulation that is used in the treatment of dehydration. And it was this mislabelling and the potential of these products to cause harm, that led Hyderabad paediatrician Dr Sivaranjani Santosh to take this case up. Dr Sivaranjani first wrote to the Central Drugs Standards Control Organisation, then to the Food Safety and Standards Authority of India and finally approached the courts to get these products to stop using ORS on their labels. Finally last month, the Delhi High Court upheld the FSSAI's ban on the use of the term ‘ORS'  in food and beverage labels, which Dr Sivaranjani termed a 'major victory for public health and consumer safety.' Guest: Dr. Sivaranjani Santosh, Hyderabad-based paediatrician Host: Zubeda Hamid Edited by Sharmada venkatasubramanian Learn more about your ad choices. Visit megaphone.fm/adchoices

•⁠ ⁠மோந்தா புயல் எப்போது எங்கு கரையைக் கடக்கும்?•⁠ ⁠தமிழ்நாட்டில் மழை தொடருமா... அடுத்தடுத்த மாதங்களில் புயல் உருவாகுமா?•⁠ ⁠தமிழ்நாடு உள்பட 12 மாநிலங்களில் சிறப்பு தீவிர திருத்தம்! - தேர்தல் ஆணையம்!•⁠ ⁠கூட்டணி கட்சிகளோடு கூட்டம் நடத்திய முதல்வர்... சார் நடைமுறைக்கு எதிர்ப்பு!•⁠ ⁠SIR நடைமுறையை மனதார வரவேற்கிறோம்! - அதிமுக•⁠ ⁠சார் நடைமுறை: நவ.2-ல் அனைத்துக் கட்சி கூட்டம்!•⁠ ⁠மாமல்லபுரத்தில் திமுக கூட்டம்... முதல்வர் பேசியது என்ன?•⁠ ⁠விஜய்க்கும் ஆதரவு... திமுகவுக்கும் ஆதரவு! - ஓ.பி.எஸ் பேட்டி•⁠ ⁠கரூர் துயரம்: 20 லட்சத்தை திருப்பிக் கொடுத்த பெண்... 30 லட்சம் கொடுக்க முன்வந்த திமுகவினர்?•⁠ ⁠மாமல்லபுரத்தில் தடுத்து நிறுத்தப்பட்ட தவெக பொருளாளர்!•⁠ ⁠நெல் மணிகள் சேதம்: தவெக தலைவர் விஜய் கண்டனம்!•⁠ ⁠நொய்யல் ஆற்றைக் காப்பாற்ற டாக்டரால் தான் முடியும்! - அன்புமணி•⁠ ⁠அரசியல் கட்சிகளின் ரோட் ஷோ வழக்கு... 10 நாள்களில் அறிக்கை தாக்கல் செய்ய அரசுக்கு நீதிமன்றம் உத்தரவு!•⁠ ⁠அரசியல் கட்சிகளுக்கு முன்கூட்டியே அனுமதி வழங்க வேண்டும்! - உயர் நீதிமன்றம்•⁠ ⁠கோவை வந்த துணை ஜனாதிபதி சிபிஆருக்கு பாரட்டு விழா!* திருச்செந்தூரில் கோலாகலமாக நடைபெற்ற சூரசம்ஹார விழா!•⁠ ⁠போலி ORS டிரிங்க்ஸை விற்க டெல்லி உயர் நீதிமன்றம் அனுமதி?•⁠ ⁠டெல்லி கலவர வழக்கு: உமர் காலித் உள்ளிட்டோருக்கான ஜாமீன் விவகாரத்தில் டெல்லி போலிஸை கண்டித்த உச்ச நீதிமன்றம்!•⁠ ⁠பெண் விவசாயி குறித்து கொச்சைக் கருத்து... மன்னிப்புக் கேட்ட கங்கனாவுக்கு ஜாமீன்!•⁠ ⁠சத் பூஜை... சாலையில் விழுந்து வணங்கிக்கொண்டே வந்த பெண்... மலர் தூவிய பாஜக அமைச்சர்!•⁠ ⁠இனவெறியால் பாலியல் வன்கொடுமை... லண்டனில் நடந்தது என்ன?•⁠ ⁠ஜப்பான் சென்ற ட்ரம்ப்புக்கு மக்கள் எதிர்ப்பு?•⁠ ⁠விக்கிபீடியாவுக்கு போட்டியாக க்ரோக்கிபிடியாவை தொடங்கிய எலான் மஸ்க்!•⁠ ⁠30,000 பேரை நீக்கும் அமேசான் நிறுவனம்?

First, The Indian Express' Anonna Dutt explains about the food regulator banning all beverages falsely claiming to contain the ORS solution.Next, we talk to The Indian Express' Nikhila Henry who discusses the Kurnool bus accident that claimed 20 lives and what a new forensic report has now revealed about how it happened. (12:48)In the end, we talk about Patna's Gandhi Maidan which has now been shut down ahead of elections. (19:40)Hosted by Ichha SharmaWritten and produced by Shashank Bhargava and Ichha SharmaEdited and mixed by Suresh Pawar

Pepe Viyuela, Sara Águeda y Bernardo Sánchez conversan con Pepa Fernández sobre los entresijos de "Guitón Onofre, el pícaro perdido", una propuesta teatral basada en la novela de Gregorio González.Pepe Viyuela encarna a Guitón Onofre, un pícaro olvidado de la literatura española del Siglo de Oro, en una versión escénica que combina teatro, humor y música barroca en directo. Acompañado por el arpa de Sara Águeda y bajo la dirección de Luis d’Ors, el espectáculo nos presenta a un antihéroe astuto, desafiante y contradictorio, que lucha por sobrevivir en un mundo que le niega todo.El texto, adaptado con fidelidad e ingenio por Bernardo Sánchez y el propio Viyuela, conserva el sabor del original del siglo XVII, al tiempo que conecta con temas actuales: el hambre, la desigualdad, la necesidad de fingir para sobrevivir, y el arte de resistir desde los márgenes. “Onofre es una venganza, es un cínico”, afirma Bernardo Sánchez, subrayando la complejidad del personaje.Además, Sara Águeda interpreta en directo la pieza "La noche tenebrosa" con su arpa, aportando una atmósfera especial en Rincón de Soto, desde donde se emite el programa.Una propuesta escénica que recupera y revitaliza la tradición picaresca española con una mirada contemporánea.Escuchar audio

•⁠ ⁠தமிழ்நாட்டில் தீபாவளிக்கு அடுத்த நாள் அரசு விடுமுறை!•⁠ ⁠கிளாம்பாக்கம் பேருந்து முனையத்தில் நேற்று நள்ளிரவில் அலைமோதிய கூட்டம்•⁠ ⁠உயர்த்தப்பட்ட விமான கட்டணம்?•⁠ ⁠தவெக அங்கீகரிக்கப்பட்ட கட்சி அல்ல - தேர்தல் ஆணையம்?•⁠ ⁠கரூர் மரணங்கள்: "ஆனந்த் பேசிய ஆதராம் என்னிடம் இருக்கிறது; விஜய்தான் முழுப்பொறுப்பு" - வேல்முருகன்•⁠ ⁠பாஜக அரசுக்கு முதலமைச்சர் மு.க.ஸ்டாலின் கேள்வி!•⁠ ⁠தொகுதி வாரியாக பொறுப்பாளர்களை நியமித்த தமிழக பாஜக •⁠ ⁠அண்ணாமலை மன்ற கொடி அறிமுகம்?•⁠ ⁠`இதுதான் பாசிசம்!' - வானதி காட்டம்•⁠ ⁠திராவிடத்தின் மாசற்ற வாரிசு அதிமுக! - எடப்பாடி பெருமிதம்•⁠ ⁠குடியரசுத் தலைவர் விளக்கம் கேட்ட விவகாரத்தில் விரைவில் தீர்ப்பு•⁠ ⁠உணவு பொருட்களில் ORS பெயருக்கு இனி தடை?•⁠ ⁠பிரதமர் மோடியுடன் இலங்கை பிரதமர் ஹரிணி அமரசூரியா சந்திப்பு

Errores de pablo d_Ors 1

Operating rooms drive both patient care and hospital finances, but they're also a major source of clinical and financial waste. Each day, U.S. ORs generate up to 2,000 tons of waste, with variations in surgical practice adding unnecessary costs. In this episode, Dr. William Payne, orthopedic spine surgeon and the president of the medical staff at Franciscan Health - Olympia Fields, and Courtney Kleeb, senior director at HealthTrust Performance Group, share strategies to reduce surgical waste, including: Defining the biggest drivers of waste in surgery Leveraging physician leadership to improve consistency and outcomes Using data and analytics to capture savings without compromising care Tune in to learn how organizations can cut waste in the OR while strengthening outcomes and financial performance.

*Content warning: disturbing abuse of children, disability abuse, emotional and physical violence involving children, murder, death, suicide, neglect, kidnapping, abduction, isolation, torture, distressing topics.  *Free + Confidential Resources + Safety Tips:  somethingwaswrong.com/resources    Snag your ticket for the live Home for the Holidays event here: https://events.humanitix.com/swwxtgi  Check out our brand new SWW Sticker Shop!: https://brokencyclemedia.com/sticker-shop Support The Gathering Inn  *SWW S23 Theme Song & Artwork:  The S24 cover art is by the Amazing Sara Stewart Follow Something Was Wrong: Website: somethingwaswrong.com  IG: instagram.com/somethingwaswrongpodcast TikTok: tiktok.com/@somethingwaswrongpodcast  Follow Tiffany Reese: Website: tiffanyreese.me  IG: instagram.com/lookieboo *Sources  "Accused killer John Free's death was a suicide, say officials." 7 News, WWNY, March 18, 2025, https://www.wwnytv.com/2025/03/18  Aldrete, Isabella, "Audit: Seven care facilities for children fail state standards." The Nevada Independent, September 20, 2024, https://thenevadaindependent.com/article  Anderson, Kayla, "New teen treatment center opens in Hawthorne." Mineral County Independent-News, December 13, 2022, https://mcindependentnews.com/2022/12/  Aurora Center for Healing. Alignable, n.d., https://www.alignable.com/hawthorne-nv  Dunn, Kenneth, "Nevada health officials suspend Aurora Center license in Hawthorne." KRNV, May 9 2025, https://mynews4.com/news/local/nevada-health  “FULL INTERVIEW with a former Academy at Ivy Ridge Worker.” YouTube, uploaded by 7News | WWNY | Watertown, May 2, 2024, https://www.youtube.com/watch Hofmann, Will, "Asheville Academy violated NC law, will face fines after child suicides report says." Asheville Citizen Times, June 18, 2025, https://www.yahoo.com/news  Jones, Andrew R., "Asheville Academy Gives Up Its License Following Two Suicides in May." Asheville.com, June 10, 2025, https://www.asheville.com/news/2025/06  Kenton, Luke, "Ex Ivy Ridge students say John Free sent ‘threatening' messages weeks before the dorm parent was charged with murder." The U.S. Sun, May 23 2024 https://www.the-sun.com/news  Kudisch, Jordan, "Asheville Academy faces $45,000 in fines after state investigation into child safety violations." Spectrum Local News, Jun. 18, 2025, https://spectrumlocalnews  Legislature, OR. “ORS 419a.245 – Use of Restraints during Transport.” OregonLaws, oregon.public.law/statutes/ors_419a.245. Accessed 23 Sept. 2025.  Nguyen, Jenny, et al. “Understanding Well-Being in Adult Survivors of the Troubled Teen Industry: The Roles of Moral Injury and Meaning-Making.” RANGE: Undergraduate Research Journal (2025), University of Utah, 1 July 2025, uen.pressbooks.pub/range26i1/chapter/jnguyen/ Rutherford, Diane, "Former Ivy Ridge worker denies sexual assault accusation, admits to mistakes." 7 News, WWNY, May 1, 2024, https://www.wwnytv.com/2024/05/01 Rutherford, Diane, "Grand jury indicts former Ivy Ridge worker on murder charges." 7 News, WWNY, January 6, 2025, https://www.wwnytv.com/2025/01/06/grand-jury  Salamone, Olivia, "Former Ivy Ridge dorm parent John Free charged with murder weeks after detailing harrowing abuse academy victims faced." The U.S. Sun, May 22 2024,https://www.the-sun.com/news/11442849/ivy-ridge-dorm-parent-murder-arrest-john-free/  Salter, Jim. “Rules Sought for ‘gooning,' Taking Troubled Kids to Care.” Youth Today, 30 Sept. 2022, youthtoday.org/2022/09/rules-sought-for-gooning-taking-troubled-kids-to-care/

Introduction In this solo episode, Darin dives into a practice that has been both revered and misunderstood across history: the enema. From ancient Egypt and Mayan rituals to Ayurveda and modern biohacking, enemas have long been used as tools for cleansing, hydration, and targeted healing. Darin shares his own two-decade experience with enemas — from parasite cleanses to coffee enemas — and explores the science, history, and red flags you need to know. This is not medical advice, but an invitation to learn from ancient wisdom and consider how these practices might support your own healing journey.     What You'll Learn 00:21 – Why enemas have been used for thousands of years, from Egypt to the Maya 01:33 – Parasite cleansing, hydration, and creating an environment for balance 02:38 – Pharaohs' “shepherds of the king's rectum” and enemas in ancient medical texts 03:20 – Ayurveda protocols for cleansing, oils, and elimination support 04:25 – The Maya's ritual use of enemas, including psychoactive delivery 05:22 – Enemas as lifesaving hydration in medical history (Murphy's Drip) 06:30 – FDA-approved microbiome enemas and rapid constipation relief 07:24 – Parasite cleanses, detox protocols, and Darin's own experiences 08:38 – Why we all live with parasites and how enemas help restore balance 09:19 – Ancient wisdom vs. modern medicine: why we need both 10:19 – Coffee enemas, liver support, detox, and peristalsis stimulation 11:20 – Lights turning back on: Darin's personal benefits from enemas 12:20 – Red flags: who should not do enemas (IBD, bleeding, surgeries, etc.) 13:47 – The importance of fiber, microbiome support, and daily practices 15:21 – Why Darin does two enemas a week and how they “turn the lights back on” 16:32 – Closing reflections: enemas as ancient tools for hydration, cleansing, and microbiome health     Thank You to Our Sponsors: Therasage: Go to www.therasage.com and use code DARIN at checkout for 15% off Our Place: Toxic-free, durable cookware that supports healthy cooking. Use code DARIN for 10% off at fromourplace.com.     Find More from Darin Olien: Instagram: @darinolien Podcast: SuperLife Website: https://superlife.com Book: Fatal Conveniences     Key Takeaway “From the pharaohs to Ayurveda to modern biohacking, enemas have always been about accessing the body in powerful ways. Used with care and wisdom, they can reawaken ancient practices of cleansing, hydration, and healing.”     Bibliography & Sources Egypt / Antiquity: Hektoen Int'l on the Shepherd of the Rectum; overview of Egyptian proctology terms. Encyclopedia Pub Ayurveda (Basti): Classical reviews and practitioner summaries of Nirūha/Anuvāsana, indications, and protocols. IJRAPCalifornia College of Ayurveda Maya ritual enemas: Carod-Artal review (2015) and De Smet et al. on ritual enemas/psychoactives; museum/archaeological overviews with ceramic scenes. ScienceDirect+1 Rectal rehydration / proctoclysis: Wilderness case report of successful rectal ORS in hemorrhagic shock; historical review of proctoclysis as standard therapy (late 19th–early 20th c.). SAGE JournalsPMC Constipation/impaction patient education: Cleveland Clinic guidance on when/how enemas are used. Cleveland Clinic Parasite obstruction (Ascaris): pediatric surgical series noting hypertonic saline enemas for colonic worm disentanglement; newer case discussions. Lippincott JournalsPMC Microbiome therapy (powerful modern rectal route): FDA approval docs and clinical literature for REBYOTA(enema) and FMT efficacy. U.S. Food and Drug AdministrationCleveland Clinic Journal of Medicine Risks & what to avoid: FDA safety communication on phosphate enemas; case report of coffee-enema proctocolitis; reviews cautioning routine “colon cleansing.” U.S. Food and Drug AdministrationPMC

Send us a text

Charla dada el 27 Agosto 2025 en Sala Zitarrosa, MontevideoEste encuentro fue a beneficio de Aletea y de Revolución del CoibríTrabajamos el sentido de la vida desde la conexión corporal, emocional, vincular, intelectual y espiriutal.La salud se mide en proyectos ! Desde la Logoterapia de Viktor Frankl y sumando el aporte de Pablo d Ors y la espiritualidad del silencio. ´

Before Justin and Dan preview Auburn vs. Baylor later this week, they go deep on some aspects of the Tigers' roster heading into the 2025 season. Topics for this episode include:* all the defensive “ORs” on the depth chart and what they mean* why that Dave Aranda quote makes more sense than some Auburn fans think* “believe it when you see it” when it comes to Auburn's offense* Baylor's defensive strengths and how Auburn might have to attack them* the pass protection questions and the commitment to the ground game* Damari Alston's first crack at becoming the Tigers' new lead back* Horatio Fields' big preseason camp and chances at starting out wide* why Dan thinks a sharp performance on either side of the ball could mean big things in SEC play* why Justin is still focused on one big stat for the Auburn offense in Week 1* Alex McPherson's health situation * Dan's review of the War Eagle+ series on the 2010 national championship teamIf you're receiving this free podcast episode and would like to upgrade to a paid subscription that gives you access to all stories and premium podcast episodes for the special price of $4/month or $40/year, subscribe using the button below or clicking this link.Follow Dan (@dnpck) and Justin (@JFergusonAU) on Twitter. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.auburnobserver.com/subscribe

Bryan Matthews, Caleb Jones and Jay G. Tate reconvene to discuss the most pressing news, which today centers around the fact that the 9-time national champion Auburn Tigers open play this Friday night! Other things discussed: • What does we expect from injured players Eric Singleton Jr. and Alex McPherson? • Lots of "ORs" on the depth chart, eh? • Do we buy Freeze's belief that depth on defense will be a strength? • Do we actually trust Jackson Arnold to be effective? • Horatio Fields is said to be the leader in the WR room. Impressive. • What does Freeze mean when he talks about Baylor's "sim pressures?" • Freeze says the pass pro has been better. That's important. • Do mistakes actually cost you? Yes. Yes, they do.  • Bralan Womack jumps on board, which gets this Auburn class back into the Top 25. What is the plan for the rest of the way?  The show is presented by VooDoo Wing Company with locations in Auburn, Mobile, Tuscaloosa, Florence, suburban Charlotte, Chapel Hill and Las Vegas. Check them out IN PERSON for delicious chicken or on the web at www.voodoowingco.com.

Send us a textWatch the video on YouTubeCan IV fluids really help with Long COVID symptoms like fatigue, dizziness, and brain fog? In this episode, Dr Khan reviews the scientific evidence on IV hydration versus oral rehydration solutions (ORS) in children, athletes, and patients with POTS (postural orthostatic tachycardia syndrome)—and shares her personal experience as both a doctor and a patient living with Long COVID.You'll learn:✔️ How IV fluids expand blood volume and why that matters in Long COVID✔️ The risks and complications of IV therapy (including when NOT to use it)✔️ What the research says about ORS vs. IV hydration in different groups✔️ Why IV fluids may serve as a temporary rescue therapy for some people with POTS or Long COVID✔️ Practical tips for safe IV use 

Ever had your surgery interrupted… by UnitedHealthcare? Yeah, me neither. But that's exactly what happened to our guest this week, the incredible Dr. Elisabeth Potter. She went viral after exposing the absurdity of insurance meddling in patient care, right down to getting pulled out of the OR for a phone call about prior authorization. In this episode, Kristin and I dig into how Dr. Potter stood up to a massive insurance company, why they tried (and failed) to shut her down with a cease-and-desist, and how she's paying the price for telling the truth. It's raw, it's maddening, it's inspiring, and it's a reminder that sometimes the bravest thing you can do in medicine is refuse to be quiet. Takeaways: Hear the unbelievable story of insurance calling Dr. Potter mid-surgery to question her patient care. Find out how a viral video and a cease-and-desist letter turned one doctor into a national advocate. Learn why hospital lawyers installed cameras in ORs after her posts and how she fought back. Discover how retaliation from UnitedHealthcare threatened her new surgery center and practice. Why thousands of people rallied behind her with donations, comments, and support and why she's not backing down. — Want more Dr. Elisabeth Potter? Instagram: @drelisabethpotter X (Twitter): @EPotterMD TikTok: @drelisabethpotter Facebook: Dr. Elisabeth Potter YouTube: @DrElisabethPotterMD Bluesky: @drelisabethpotter.bsky.social To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: https://glaucomflecken.com/glauc-to-me/ If you are interested in buying a book from one of our guests, check them all out here: https://www.amazon.com/shop/dr.glaucomflecken If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: https://anatomywarehouse.com/?aff=14 Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

Durant l'été, je vous propose une sélection des meilleurs épisodes de Vlan sur la dernière saison. L'occasion de découvrir ou redécouvrir des épisodes qui ont énormément plu. Anne-Clotilde Ziegler, psychothérapeute et autrice de quatre ouvrages sur l'emprise et les pervers narcissiques, est mon invitée cette semaine.Cela fait un moment que je me questionne sur la perversion narcissique et ensemble, nous plongeons dans la complexité des relations toxiques, un sujet qui suscite énormément de débats. Pourquoi ce thème me tient-il tant à cœur ? Parce que je crois qu'il est crucial de faire la lumière sur des réalités souvent minimisées car c'est devenu un terme tellement générique. Ors quand tout le monde devient "pervers narcissique" alors plus personne ne l'est et on invisibilise la réalité des personnes victimes.Avec Anne-Clotilde, nous discutons de ce que signifie réellement l'emprise, de ses mécanismes insidieux, des caractéristiques des personnalités dites perverses narcissiques et, surtout, de la manière de s'en sortir.Anne-Clotilde nous éclaire avec une grande clarté sur les dynamiques psychologiques en jeu, tout en déconstruisant les idées reçues sur ces relations. Si vous avez déjà traversé une situation d'emprise, si vous voulez comprendre ces phénomènes pour mieux vous en protéger ou simplement aider un proche, cet épisode est pour vous. Vous verrez aussi que les victimes d'emprise sont souvent des personnes brillantes, généreuses, et que cette générosité peut être leur plus grande faiblesse. J'espère que ce moment passé avec nous pourra vous apporter un peu plus de sérénité et de clarté.Une partie des questions que nous traitons : Qu'est-ce que l'emprise et en quoi diffère-t-elle d'une relation conflictuelle ?Quels sont les signes révélateurs d'une personnalité perverse narcissique ?L'emprise est-elle genrée, touchant majoritairement les femmes ?Comment expliquer la fascination des pervers narcissiques pour les personnes brillantes ?Pourquoi est-il si difficile pour les victimes de se libérer de l'emprise ?Quelles sont les étapes pour sortir d'une relation d'emprise ?Comment l'entourage peut-il soutenir une victime sans la brusquer ?Les enfants souffrent-ils davantage d'un maintien du couple ou d'un divorce dans ces situations ?Existe-t-il des méthodes pour prévenir l'emprise avant qu'elle ne s'installe ?Peut-on véritablement « guérir » un pervers narcissique ?Timestamps : 00:00 : Introduction au thème de l'emprise et aux idées reçues.01:41 : Pourquoi les victimes d'emprise sont souvent des personnes brillantes.04:44 : Qu'est-ce que l'emprise ? Définition et nuances importantes.09:49 : Les caractéristiques des personnalités perverses narcissiques.19:10 : Comment les manipulateurs isolent leurs victimes.24:15 : Les signes d'alerte pour détecter une situation d'emprise.33:03 : Pourquoi les pervers narcissiques sont conscients de leurs manipulations.40:01 : Les étapes pour se libérer de l'emprise.47:33 : Le rôle crucial de l'entourage dans le processus de guérison.54:42 : Refaire confiance et reconstruire sa vie après une relation toxique. Suggestion d'autres épisodes à écouter : Vlan #121 Comment la communication non violente peut améliorer vos relations? avec Thomas d'Ansembourg (https://audmns.com/roooEEk) #245 comprendre les secrets des liens affectifs avec Gwenaelle Persiaux (https://audmns.com/hNGTIqO) #264 Réinventer les relations amoureuses libérées des contraintes sociales avec Franck & Vanessa Lopvet (https://audmns.com/hEsJSqT)Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

The long-running lawsuit against the Office of Retirement Services (ORS) over superintendent compensation may be settled, but the implications are still unfolding. In this episode, we sit down with Dr. Tina Kerr, Executive Director of the Michigan Association of Superintendents and Administrators, and Bob Schindler, attorney at Miller Johnson and legal representative in the case, to break down what the settlement means for districts. Learn what steps administrators can take now to prepare for the coming changes to superintendent retirement compensation.

We desperately want our ORs to be efficient. So do our surgeons. So why does it feel like productive engagement and communication is often easier said than done? As daunting as it may sometimes seem, engaging with our surgeons is crucial to improving efficiency, communication, and collaboration in the OR. In this episode of First Case, we're joined by orthopedic surgeon and DOCSI CMO Dr. Pearce McCarty, who offers an open and honest look at how perioperative staff can better engage with surgeons—without conflict, frustration, or being ignored. From the constant struggle with preference card accuracy to communication failures, we're going to discuss some of the real-life challenges we face in the OR. Tune in to learn how to approach surgeons more effectively, start conversations that actually lead to change, improve preference card accuracy and reduce waste, and create more efficient, collaborative surgical teams. Don't miss this eye-opening conversation! #operatingroom #ornurse #surgery #perioperative #perioperativenurse #communication #ScrubTech #SurgicalTechnologist #podcast

Staffing shortages and burnout have left many ORs struggling to stay efficient — but what if there was a simple solution that gave you time back while also protecting your sterile field? In today's First Case Vendor Spotlight™, we're going to learn all about this time and staff saving solution with Laurel Stebbins, Clinical Manager, and Alex Navlet, Clinical Consultant, with TIDI Products, along with Maria Candelaria, a perioperative nurse and current user of the Sterile-Z® drape. The Sterile-Z® is a game-changing drape that helps surgical teams stay efficient, compliant, and stress-free. In this discussion, we'll hear firsthand how this clear, easy-to-use drape improves workflow, reduces contamination risk, and even helps teams take a much-needed break — without compromising sterility. The Sterile-Z® line now includes options for Mayo stands and 3D imaging procedures, all designed to save time, reduce waste, and protect your setup from airborne contamination. To learn more or request a sample, visit tidiproducts.com/sterile-z and follow them on LinkedIn, Facebook, Instagram, and TikTok! #operatingroom #sterilefield #surgicalefficiency #ORNurse #scrubtech #perioperative #vendorspotlight #podcast #SterileZ

Send us a textAbout Julie Rodman, OD, MSC, FAAODr. Julie Rodman is the Chief of the Broward Eye Care Institute in Fort Lauderdale, FL and a Professor of Optometry at Nova Southeastern University. She also is the Instructor of Record for Posterior Segment Disease at the College. Her research interests include OCT/OCTA and Vitreoretinal Disease. Dr. Rodman has authored over thirty publications with an emphasis on retinal disease. She recently published “Optical Coherence Tomography Atlas: A Case Study Approach”, the first reference book on this topic written by an optometrist. Dr. Rodman is a member of the AOA, AAO, FOA, and ORS. She has been the recipient of numerous teaching awards, was recognized as a Primary Care Optometry News “Top 300” Optometrists and “Newsweek Best Optometrists of 2023”.

Surgical smoke isn't just unpleasant—it's dangerous. In our latest First Case: Articles on the Go episode, we shed light on the harmful particles released during common surgical procedures—and the risks they pose to perioperative professionals. Despite decades of research confirming the presence of carcinogens, mutagens, and infectious material in surgical smoke, consistent regulation and protection remain lacking in many ORs. This episode explores: The health hazards associated with surgical smoke exposure The importance of smoke evacuation systems Legislative progress across the U.S. How perioperative professionals can educate, advocate, and drive change Listen now! ----- Articles On-the-Go presents perioperative insights from written articles in a creative, easy to listen, audio format. Think audio book, meets busy Operating Room professional! #operatingroom #perioperativenurse #firesafety #fireprevention #surgery #scrubtech #surgicaltechnology